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Welcome to NNPC 2015 in Visby! 
 
On behalf of the Organizing Committée, we have the honour to welcome 
you to the 6th Nordic Natural Products Conference in Visby, and a joint 
venture between the Division of Pharmacognosy at Uppsala University and 
the Swedish University of Agricultural Studies. 
 
This conference is presented under the sub-heading of 
"Natural Products Research – Past Present and Future" 
in honour of Prof. Lars Bohlin,  
who has for many year been a driving force in the development 
of natural products research in the Nordic countries. 
 
The series NNPC was initiated by Prof. Bohlin in 2005, and the first 
meeting was pursued exactly ten years ago, 13-15 June, at Tjärnö 
Marinbiologiska Station outside the city of Strömstad on the Swedish west-
coast.  
 
Among the 70 participants at NNPC 2005, we find several contributors of 
this years meeting, including (but not limited to): A.-K. Borg-Karlsson, A. 
Brogren, H. R. El-Seedi, A.K. Jäger, S. Larsson, K.E. Malterud, T. Ostenfeld 
Larsen, R. Riccio, K. J. Rosengren, B. Smestad Paulsen, D. Stærk, and H. 
Wangensteen. 
 
With 87 registered participants from California to Taiwan, and Iceland to 
Sri-Lanka, this meeting at Uppsala University Campus Gotland on the Baltic 
island of Gotland shows that NNPC has become established as an 
important meeting-place for natural products researchers not only in the 
Nordic countries, but also worldwide.    
 
The broad scope of the meeting, open for all aspects of studies in natural 
products, is in this years program pronounced by mingling presentations 
from different disciplines. It is our hope that this will even further foster 
interdisciplinary research and intefacing idéas for the years to come.  
  
Again, welcome to Visby! 
 
10th of June 2015 
 
 
 
Anders Backlund, Chairman               Ulf Göransson, Vice Chairman 	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PROGRAMME for NNPC 2015 
Nordic Natural Products Conference 
(14-) 15-16 June 2015, Uppsala University Campus Gotland, Visby 
 
 SUNDAY 2015.06.14 . 
 
 20.05-23.20 Registration and Welcoming Reception at M/S Visby. 
 
 
 
 
 MONDAY 2011.08.15 . 
 
 
 09.30-09.45 Opening Ceremony:  
 By 7th ECMNP Chairman Prof. Anders Backlund and  
 the Governor of Gotland: Cecilia Schelin-Seidegård 
 
 
 09.45-10.45 SESSION I CHAIRMAN: Anders Backlund . 
 
 
 09.45-10.15 Lars Bohlin   L01 
 Modern pharmacognosy – 40 years of experience in  
 natural products research 
 10.15-10.45 Raffaele Riccio   L02 
 Disclosing biological targets of bioactive natural products 
 by chemical proteomics 
 
 10.45-11.15 MORNING COFFEE 
 
 
 11.15-12.00 SESSION II CHAIRMAN: Christina Wedén . 
 
 
 11.15-11.30 Adyary Fallarero  L03s 
 Strategies to protect medical devices from biofilm infections 
 11.30-11.45 Joakim Bjerketorp  L04s 
 New antibiotics from nature: SLU-Medivir collaboration 
 11.45-12.00 Erik Jacobsson   L05s 
 Peptide toxins from L. longissimus: extraction, biological 
 activity, structure and production 
 
 12.00-13.30 LUNCH supported by Medivir  
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 MONDAY 2015.06.15 . 
 
 
.13.30-15.00 SESSION III CHAIRMAN: Anders Broberg . 
 
 13.30-14.00 Lena Gerwick   L06 
 Honaucin A, mechanism of action and role as a cancer prevention agent 
 14.00-14.15 Sesselja Omarsdottir  L07s 
 Immunomodulatory effects of novel N-acyl dopamine derivatives,  
 myxillin A, B and C from the sponge Myxilla incrustans collected 
 at submarine geothermal chimneys in Northern Iceland 
 14.15-14.30 Håkan Andersson  L08s 
 Discovery of peptide toxins in the world's longest animal  
 (the bootlace worm; Lineus longissimus): challenging claims of  
 tetrodotoxin production 
 14.30-14.45 Anna Jäger   L09s 
 Finding the world's best plants for type-2 diabetes targets 
 14.45-15.00 Sonny Larsson   L10s 
 Life-and-death pharmacognosy – or: What did we have for dinner? 
 
 15.00-15.30 AFTERNOON TEA  
 
 
 15.30-17.30 SESSION IV CHAIRMAN: Ulf Göransson . 
 
 15.30-16.00 Marcel Jaspars   L11 
 Extreme structure determination 
 16.00-16.15 Henrik Toft-Simonsen  L12s 
 The quest for large amounts of Thapsigargin 
 16.15-16.30 Anna Koptina   L13s 
 Sialidase enzyme as a novel drug target against trichomoniasis 
 16.30-17.00 Nina Rønsted   L14 
 Phylogenetic exploration of medicinal plant diversity.  
 Can the evolutionary history of plants help guide better healthcare,  
 new leads, and sustainable use of medicinal plants? 
 
 17.00-17.30 Anders Backlund 
 Information regarding poster session 
 
 
 17.30–21.00 POSTER SESSION  . 
 
 
 EVENING MEAL supported by Region Gotland   
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 TUESDAY 2015.06.16 . 
 
 
 08.30-10.00 SESSION V CHAIR: Jolanta Levenfors . 
 
 
 08.30-09.00 Johan Rosengren  L15 
 PawS-derived peptides: A diverse family of cyclic plant  
 peptides from sunflowers 
 09.00-09.15 Paco Cárdenas   L16s 
 Sponge taxonomy 2.0 meets pharmacognosy 
 09.15-09.30 Malena Skogman  L17s 
 Cinchona alkaloid derivatives as antibacterial  
 and anti-biofilm chemotypes 
 09.30-09.45 Taj Muhammad  L18s 
 A new biological tool for disulfide-rich cyclic peptide synthesis:  
 Application of PatG macrocyclase enzyme in the synthesis of  
 cyclotides and sunflower trypsin inhibitor 1 
 09.45-10.00 Madeleine Ernst  L19s 
 From ethnomedicine to phylogenetic prediction in drug discovery  
 in the genus Euphorbia: Suggestions for a new classification  
 system of diseases 
 
 
 10.00 - 10.30 MORNING COFFEE 
 
 
 10.30-12.00 SESSION VI CHAIR: Corine Sandström . 
 
 
 10.30-11.00 Dan Staerk   L20 
 High resolution bioactivity profiling combined with hyphenated  
 HPLC-HRMS-SPE-NMR for accelerated identification of  
 bioactive natural products directly from crude extracts 
 11.00-11.15 Rime El-Houri   L21s 
 Polyacetyenes from carrots (Daucus carota) with potential  
 antidiabetic effects 
 11.15-11.30 Muaaz Al-Ajlani  L22s 
 Notes on chemical property position of bedaquiline constructed  
 by the chemical global positioning system ChemGPS-NP 
 11.30-11.45 Blazej Slazak   L23s 
 Immunolocalization of cyclotides in plant cell, tissue and organs  
 support their role in plant defence 
 11.45-12.00 Karl-Egil Malterud  L24s 
 Zanthoxylum heitzii, a possible anti-malaria medicine 
 
 
 
 
 12.00-13.30 LUNCH supported by Galderma  
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 TUESDAY 2015.06.16 . 
 
 
 13.30-15.00 SESSION VII CHAIR: Adam Strömstedt . 
 
 
 13.30-14.00 Gerhard Ecker   L25 
 Open innovation and data integration – from docking poses  
 to prediction of side effects 
 14.00-14.15 Anders Broberg  L26s 
 Sesquiterpenes from the saprotrophic fungus  
 Granulobasidium vellereum 
 14.15-14.30 Xia-Xia Di   L27s 
 Bio-guided fractionation of immunomodulatory compounds  
 from the marine sponge Halicondria sitiens 
 14.30-14.45 Shaikh Jamal Uddina  L28s 
 Central-stimulating and analgesic activity of the ethanolic  
 extract of Alternanthera sessilis in mice 
 14.45-15.00 Sileshi Wubshet  L29s 
 Ligand fishing using functionalized beads combined with  
 HPLC-HRMS-SPE-NMR: Analysis of α-glucosidase  
 inhibitors in a crude plant extract 
 
 
 15.00-15.30 AFTERNOON TEA  
 
 
 15.30-17.00 SESSION VIII CHAIR: Lars Bohlin . 
 
 
 15.30-16.00 Anna-Karin Borg-Karlsson  L30 
 Chemical ecology 
 16.00-16.15 Sunithi Gunasekera  L31s 
 Circular disulfide-rich peptide scaffolds as anti-citrullinated  
 peptide antibody inhibitors 
 16.15-16.30 Thomas Ostenfeld-Larsen  L32s 
 Fungal natural product chemistry in the genomic era 
 16.30-17.00 William Gerwick  L33 
 Interdisciplinary approaches to marine natural products  
 drug discovery 
 
 
 17.00-17.30 Closing ceremony 
 
 
 19.00– CONFERENCE BANQUET  . 
 
 at Hotel Visby, supported by BergmanLabora  
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REGISTRATION and RECEPTION 
 
The registration and welcoming reception will start in the conference room 
onboard M/S Visby after departure from Nynäshamn on Sunday 2015.06.14. 
 
Registration will continue at Scandic Hotel Visby in the evening 2015.06.14, 
and at the congress venue from 08.00 on the 2015.06.15. 
 
 
POSTER SESSION 
 
The posters are mounted upon arrival and are displayed adjacent to the 
lecture hall throughout the conference. The poster session is set for Monday 
evening starting at 17.30.  
 
There will be a wine and beer bar opening at 18.00, and all participants are 
provided with tickets for a complimentary drink and a hamburger served by 
restaurant Smakrike and supported by Region Gotland. Soft drinks and 
snacks will be served for free. 
 
 
VENUE 
 
The conference venue is Almedalsbiblioteket, lecture hall E22.  
 
Address: 
Almedalsbiblioteket E22 
Cramérgatan 5 
621 22 Visby 
Tel: +46 (0)498-29 90 00 
 
http://www.almedalsbiblioteket.se/english/Welcome.html 
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SUPPORT FROM THE FOLLOWING 
 
NNPC 2015 - PARTNERS  
 
IS GRATEFULLY ACKNOWLEDGED 
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L01 – 2015.06.15, at 09.45-10.15 
 
Modern pharmacognosy – 40 years of experience  
in natural product research 
 
L. Bohlin 
 
 
Div. of Pharmacognosy, Dept. of Medicinal Chemistry, Uppsala Univ., Sweden 
 
 
The subject Pharmacognosy at Uppsala University, with a long history and 
connected to the famous Uppsala scientist Carl Linnaeus, is responsible for 
teaching and research in the area of bioactive novel molecules with medicinal 
potential from natural sources. The subject combines chemistry with biology in a 
multidisciplinary way. This type of approach is necessary in order to discover, 
describe, and communicate the richness of nature to overcome threats against 
biodiversity and the future sustainable use of natural resources. The ultimate 
purpose being to secure molecules with natural origin as potential leads in drug 
development and also to reveal potential new targets. Discovery of novel 
structure-activity relationships in nature has also an increased importance for 
inspiration of synthesis of natural product like compounds resulting in greater 
diversity but with less complexity and increased understanding of biological 
processes. Identifying bioactive molecules from complex biomasses requires 
careful selection and execution of relevant bioassays in the various stages of the 
discovery process of potential leads and targets. The aim of this lecture is to 
share our long-term experience in bioassay-guided isolation, and mechanistic 
studies, of bioactive compounds from different organisms in nature. A long-term 
research has provided experience of selection and combination of bioassay 
models, which has led to an increased understanding of ethnopharmacological 
and ecological observations, together with in depth knowledge of mode of action 
of isolated compounds 
 
 
References: 
1. Bohlin, L., Alsmark, C., Göransson, U., Klum, M., Wedén, C. and Backlund, A. 
Strategies and Methods for a Sustainable Search for Bioactive Compounds, 
Chapter 1, pp. 1-36, (2011) 
2. Strömstedt, A.A., Felth, J. and Bohlin, L. (2014). Phytochemical Analysis, 25(1), 
13-28. 
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L02 – 2015.06.15, at 10.15-10.45 
 
Disclosing biological targets of bioactive natural  
products by chemical proteomics 
 
R. Riccio, A. Casapullo, M.C. Monti, C. Cassiano, and L. Margarucci 
 
Department of Pharmacy, University of Salerno, Fisciano, Italy, 
 
The identification of the cellular targets of bioactive small-molecules is often a 
crucial step during the investigation of natural products. This aspect is particularly 
relevant in pharmaceutical research, where the identification of target proteins 
and investigation of ligand-receptor interactions are recognized as essential 
requirements in the process of drug D&D. Owing to our involvement in the field of 
bioactive natural products, we are investigating different strategies toward target 
identification, based on computational approaches (1-3) or on chemical 
proteomics (4-10). Both protocols appear to be attractive alternatives to in vitro 
binding assays, since they can be easily and extensively applied in the early 
stages of the process of drug D&D from bioactive small-molecules of synthetic or 
natural origin. Indeed, target identification is, in principle, feasible through a 
chemical proteomics protocol based on a combination of affinity purification 
(pulldown) using suitable small-molecule probes that have been incubated in a 
cell culture or in a cell lysate and of mass spectrometric identification of the set of 
captured proteins. The molecular probe (the bait) is made up by anchoring the 
compound under investigation onto a solid support through a flexible spacer arm. 
This matrix is then incubated with an opportune lysate, from cells or tissues, to 
promote the interaction between the bait and its specific protein targets. The 
fished proteins are eventually isolated and identified through MS methodologies. 
In this communication we will present the in vitro and in cell chemical proteomics 
approaches used in our lab, through the most recent results obtained on a set of 
bioactive marine natural products: Heteronemin (11), Theonellasterone (12) and 
Scalaradial (13). 
 
References:  
1. Lauro, G. et al. (2011) J. Nat. Prod. 74 (6), 1401–1407. 2. Lauro, G. et al. 
(2012) Bioorg. Med. Chem. 20 (11), 3596–3602. 3. Jun Gong, et al. (2014) Org. 
Lett. 16(8), 2224-2227. 4. Margarucci, L. et al. (2010) Angew. Chem. Int. Ed. 49, 
3960–3963. 5. Margarucci, L. et al. (2011) Mol. BioSyst. 7, 480–485. 6. 
Margarucci, L. et al. (2012) Mol Biosyst 8, 1412-1417. 7. Cassiano, C. et al. 
(2012) ChemBioChem 13 (13), 1953–1958. 8. Vilasi, A. et al. (2013) Mar. Drugs 
11, 1288-1299. 9. Margarucci, L. et al. (2013) Chem. Commun. 49, 5844-5846. 
10. Cassiano, C. et al. (2015) Natural Product Communications, in press. 11. 
Cassiano, C. et al. (2014) Chem. Commun., 50, 406-408. 12. Margarucci, L. et al 
(2015) Chem. Commun., 51(9), 1591-1593. 13. Cassiano, C. et al. (2014) Chem. 
Commun., 50 (45), 6043-6045.  
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L03s – 2015.06.15, at 11.15-11.30 
 
Strategies to protect medical devices  
from biofilm infections 
 
A. Fallareroa, T. Ojab, M. Skogmana, S. Mannerb, D. Goeresc,  
N. Sandlerb and P. Vuorelaa  
 
 
aPharmaceutical Biology, Div. of Pharmaceutical Biosciences, Univ. of Helsinki, 
Finland.  
bPharmaceutical Sciences, Åbo Akademi University, Turku, Finland,  
cCenter for Biofilm Engineering, Montana State University, Bozeman, USA. 
 
Biofilm-related infections (BRIs) are chronic, resilient and highly tolerant 
infections that differ from the acute ones caused by single-cell microbes. An 
estimated 65-80% of all infections are thought to be biofilm-related, particularly 
those occurring in indwelling medical devices [1], such as prosthetic joints, 
fracture-fixation as well as devices used in plastic surgery, urology and 
neurosurgery. For orthopaedic implants alone, biofilm infections cause up to 25% 
of surgical failures, costing € 800 million/year. We propose here an innovative 
strategy to protect medical devices involving the use of printing technologies to 
produce individualized implants containing effective antimicrobials that can 
prevent bacterial colonization and minimize tissue-remodelling needs. Three key 
challenges were identified and addressed on, during this project. First: assays to 
measure the anti-biofilm activity in printed materials were needed. This we 
tackled by optimizing the so-called Static Biofilm Assay, which serves as a model 
for the testing of nearly any kind of fabricated materials against bacterial biofilms 
grown in the absence of shear flow [2]. Second: effective anti-biofilms were 
needed. In this case, we took advantage of the collection of natural and naturally 
inspired biofilm inhibitors identified by our lab, which are highly potent even 
against pre-formed biofilms [3]. Third: proofs of the technological feasibility of this 
approach were needed. Indeed, we showed that it is technically feasible to 
incorporate antimicrobials into the carrier polymer used for 3D printing (using hot 
melt extrusion), which results in a dramatic inhibition of biofilm formation in vitro 
when compared to a coated surface [4]. These findings pave the way for new 
natural products applications to better protect medical devices against biofilms. 
 
Acknowledgements: Academy of Finland grants 272266 (ArtFilm) and 282981 
(WoodyFilm) are acknowledged. 
 
References: 
1. Beloin, C. et al. (2014) Curr Opin Pharmacol. 18:61-8.  
2. Oja, T. et al. (2014) J Microbiol Methods.107:157-60.  
3. Manner, S. et al. (2013) Int J Mol Sci. 14(10):19434-51.  
4. Sandler, N. et al. (2014) Int J. Pharm. 459:62-64.   
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L04s – 2015.06.15, at 11.30-11.45 
 
New antibiotics from nature: SLU-Medivir collaboration 
 
J. Bjerketorpa, J.J. Levenforsa, B. Gussa, J. Schnürera, P. Anderssonb, A. 
Brobergb, C. Nordb, K. Benkestockc, K. Göhlinc, C. Sahlbergc, L. Vrangc, F. 
Öbergc, B. Öbergc, and R. Bethellc 
 
 
aDepartment of Microbiology, BioCentrum, Swedish University of Agricultural 
Sciences (SLU), P.O. Box 7025, SE-750-07 Uppsala, Sweden.  
bDepartment of Chemistry and Biotechnology, BioCentrum, Swedish University of 
Agricultural Sciences (SLU), P.O. Box 7015, SE-750-07 Uppsala, Sweden.  
cMedivir AB, P.O. Box 1086, SE-141 22 Huddinge, Sweden. 
 
The increase of antibiotic resistance is recognized as one of mankind’s greatest 
challenges – new antibiotics are urgently needed [1, 2]. The challenges to 
antibacterial discovery have kept the output of novel antibacterial drug classes at 
extraordinarily low levels over the past 50 years and rational drug design of new 
compounds has failed.  
International expert organizations, such as Infectious Diseases Society of 
America (IDSA) and British Society for Antimicrobial Chemotherapy (BSAC) 
proposes a return to nature as a place to find new antibiotics [3].  
Collaboration between SLU and Medivir started in August 2012. It has a primary 
objective to discover and develop new antibiotics that are active against bacterial 
pathogens resistant to present therapies. Bacterial and fungal isolates from the 
existing SLU-collection as well as microorganisms that are isolated from new 
environmental samples are used as a source for isolation of secondary 
metabolites with antibacterial activity. 
Since then, over three hundred antibacterial natural products were isolated and 
at least partially characterized, and many of these were novel compounds. The 
discovered molecules have varying antimicrobial profiles and capacity to inhibit 
the growth of bacterial pathogens, some of them resistant to existing drug 
therapies. 
 
References: 
1. The Review on Antimicrobial Resistance (11th December 2014) Antimicrobial 
Resistance: Tackling a crisis for the health and wealth of nations. UK 
Government and Wellcome Trust. 
2. National action plan for combating antibiotic-resistant bacteria (27th March 
2015) The White House. 
3. Infectious Diseases Society of America, 2010: The 10 × '20 Initiative: Pursuing 
a Global Commitment to Develop 10 New Antibacterial Drugs by 2020. Clinical 
Infectious Diseases 50, 1081-1083.    
 
 
 
 
 
  
21 
L05s – 2015.06.15, at 11.45-12.00 
 
Peptide toxins from L. longissimus: extraction, biological  
activity, structure and production 
 
E. Jacobssona, H.S. Anderssonb, M. Strandc,  
C. Erikssona, and U. Göranssona   
 
 
aDiv. fo Pharmacognosy, Dept. Medicinal Chemistry, Uppsala University, Sweden.   
bCentre for Biomaterials Chemistry, Dept. Chemistry and Biomedical Sciences, 
Linnaeus Univ., Kalmar, Sweden.  
cDept. Biological and Environmental Sciences, Univ. of Gothenburg, Sweden.  
 
 
One of the more spectacular marine invertebrates found in Swedish waters is the 
nemertean worm Lineus longissimus. L. longissimus may reach a length of up to 
30-50 m [1,2], and is considered to be the longest animal on earth. It predates on 
small crustaceans and polychaetes and uses, in analogy to Conus spp., a 
proboscis to catch its pray. The worm is covered in mucus, which it secretes to 
facilitate movement and to deter predators. The constituent responsible for L. 
longissimus mucus toxicity was generally believed to be TTX, or analogues 
thereof [3]; however, we recently determined that TTX is not present in L. 
longissimus mucus. In this study we show that the crustacean toxicity is instead 
due (at least partly) to peptide toxins present in the mucus. We also give an 
estimation of the effective dose in the green shore crab Carcinus maenas, the 
preliminary structure of the most abundant peptide toxin and bioinformatic 
insights into the putative toxin content of the L. longissimus transcriptome. 
 
Mucus from L. longissimus was lyophilized and major peptide components were 
isolated using SEC, HPLC-UV and sequenced by means of UPLC-MS/MS with 
aid of transcriptomic data obtained by NGS (Illumina HiSeq2000 platform). The 
most abundant peptide was synthesized using SPPS to yield sufficient amounts 
for C. maenas bioassay [4] and NMR-based structural elucidation.  
 
 
References:  
1. Andrade, S. C. S. et al. (2014) Mol. Biol. Evol. 31: 3206–15.  
2. Strand, M., Sundberg, P. (2010) Nationalnyckeln till Sveriges flora och fauna – 
stjärnmaskar – slemmaskar. Artdatabanken, SLU, Uppsala.  
3. Carroll, S. et al. (2003) J. Exp. Mar. Bio. Ecol. 288: 51–63.  
4. Kem, W. R. (1971) Toxicon 9: 23–32.  
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L06 – 2015.06.15, at 13.30-14.00 
 
Honaucin A, mechanism of action and role as a  
cancer prevention agent.  
 
L. Gerwick, S. J. Mascuch, G. Navarro, P. Boudreau, and W. H. Gerwick  
 
 
Center for Marine Biotechnology and Biomedicine, Scripps Institution of 
Oceanography, University of California, San Diego, California 92093 
 
 
Three related natural products, the honaucins A-C, were isolated from a 
cyanobacterium overgrowing a coral reef in Hawaii. Subsequent biological 
investigations revealed that these molecules inhibit both prokaryotic quorum 
sensing and eukaryotic inflammation. The honaucins were originally identified as 
molecules of interest in an in vitro assay that quantified its ability to attenuate 
nitric oxide production in LPS-stimulate macrophages. Continued experiments 
using honaucin A displayed a transcriptional down-regulation of IL-6, TNFα, IL-1β, 
and iNOS in these cells. Additionally, in vivo anti-inflammatory activity in a murine 
model of ear edema was demonstrated. In order to uncover the mechanism of 
action of honaucin RNA deep sequencing was performed using RNA from 
honaucin A-treated macrophages. Analysis of differentially-regulated transcripts 
strongly suggested that honaucin A is an activator of  a pathway which results in 
the transcription of cytoprotective genes. This signaling pathway has recently 
drawn interest for its potential application to the treatment of neurodegenerative 
and autoimmune diseases, as well as cancer. Experiments involving reporter 
assays and protein pull down using a biotinylated probe to validate the proposed 
target will be discussed. 
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Immunomodulatory effects of novel N-acyl dopamine 
derivatives, myxillin A, B and C from the sponge Myxilla 
incrustans collected at submarine geothermal chimneys in 
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In this project sponges collected at unique submarine shallow water geothermal 
chimneys, north of Iceland, were investigated for their potential for anti-
inflammatory drug discovery. The purpose of this study was to utilize UPLC-
QTOF for bio-guided profiling of new compounds in sponges.  
 
Thirtyfive sponge specimens were collected at the hydrothermal vent site by 
scuba diving. Extracts were prepared by CH2Cl2:MeOH (1:1) solvent extraction 
and further fractionated with a modified Kupchan solvent partition, giving four 
fractions of different polarity. The fractions were analyzed with UPLC-QTOF 
assay and data evaluation performed with MarkerLynx and EZinfo. 
 
The sponge, Myxilla incrustans was found to have novel chemistry and pure 
compounds were isolated by prepartive-HPLC. The structures of three new N-
acyl dopamine derivatives named myxillin A,B and C, were elucidated by 1D and 
2D NMR spectroscopy and HR-MS data. The immunomodulatory effects of 
myxillin A was tested in a human monocyte-derived dendritic cells (DCs) model 
(1) and preliminary results indicate a 30% reduction in IL-12p40 secretion by 
treated DCs compared to untreated cells and no effects on IL-10 secretion at 
10µg/ml. None of the compounds were cytotoxic at 100µg/ml.  In conclusion, 
three new N-acyl dopamine derivatives were isolated from M. Incrustans and 
myxcillin A has a moderate immunomodulatory effects in vitro.  
 
Acknowledgements: Doctoral grant and project grant of The University of 
Iceland Research Fund; Icelandic Research Fund 
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Discovery of peptide toxins in the world’s longest animal 
(The bootlace worm; Lineus longissimus): challenging 
claims of tetrodotoxin production 
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Approximately 1300 species of ribbon worms (Nemertea) have been identified 
worldwide. Most species are predators living in marine environments, which hunt 
their prey by everting a proboscis containing a mixture of toxins which brings on 
rapid paralysis [1]. Another characteristic of ribbon worms is a thick layer of 
mucus on the epidermis, seemingly constituted by a similar mixture of toxins. 
Among these toxins, the highly potent neurotoxin tetrodotoxin (TTX) has been 
identified [2-5]. The toxicity of TTX (lethal by ingestion of 0.5-2 mg [6]) stems 
from its ability to block voltage-gated sodium channels [7]. Although several 
bacterial species, among these Vibrio sp. have been linked to its synthesis, the 
biogenic origin and biosynthesis of TTX is unclear [8]. One hypothesis is that TTX 
production occurs In a symbiotic relationship with its host, which in this case 
would be a ribbon worm [5]. 
 Inspired by earlier observations, we developed a setup for TTX production 
where Vibrio alginolyticus was cultivated in nutrient broth infused with mucus 
from bootlace worm, Lineus longissimus. Injections of fractions into shore crabs 
were used as an indicator of toxicity. A compound of near identical molecular 
weight to TTX was observed, but LC retention and MS fragment ions showed that 
this compound is unrelated to TTX. These observations highlight the risk for 
erroneous assessment in studies of TTX production. 
 In addition, it could be shown that toxicity was not a product of the Vibrio 
culture, but that it rather originates from the bootlace worm mucus. LC-MS 
analyses indicated the presence of peptides in the toxic mucus fractions, which 
could be linked to the toxic effect. We suggest that the paralytic effect of L. 
longissimus mucus can be explained by the presence of toxic peptides, and that 
our result may point at the need to reinvestigate some published claims of TTX 
production.  
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Finding the world’s best plants for type-2 diabetes targets 
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The number of people afflicted by type-2 diabetes is rapidly increasing. 382 
million people in the world are estimated to have type-2 diabetes today. In 
Denmark, more than 20 % of the population is afflicted, meaning that one in four 
adults are affected. Currently, there are very few herbal products on the marked 
in Denmark for management of type-2 diabetes. This prompted the aim of our 
new project: identifying the best plants in the world for the various targets 
involved in type-2 diabetes. Our research takes its starting point in 
ethnopharmacological research already performed, mining results, selecting the 
most promising candidates, then evaluating them in our lab, to find the truly 
promising plants. Preclinical data are required if herbal products are to be 
registered with the health authorities, and thereby becoming available for the 
patients.  
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Life-and-death pharmacognosy — or: 
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In the Western world human poisonings with plants or fungi are uncommon. 
Based on phone calls to Poison Information Centres they constitute 1-13% of 
inquiries depending on age group. The higher numbers are seen among young 
children, and the vast majority of cases are completely benign requiring no 
specific treatment.  
 
Severe cases of poisoning occur for three reasons: 1) intentional self-harm, 2) 
drug-seeking behaviour, or 3) lack of knowledge of how to correctly identify 
edible species when foraging for mushrooms or plants for food. All of these 
reasons are usually associated with older teenagers to young adults, though the 
third reason is common in all adult age groups especially when it comes to fungi. 
 
In Sweden there is a small number of species of wild plants and fungi capable of 
causing deadly poisonings unless eaten as a meal, and only a few are added 
even if eaten in substantial quantities. Due to the difficulties of identifying 
mushrooms the Swedish Poison Information Centre has a collaboration with 
mycologists, but no such provision is found when it comes to plant ingestions. 
Thus for the most part putative plant identities are deduced from the presented 
symptoms, and advice on treatment and possible progression of the poisoning 
become rather uncertain. 
 
Here I will report on a poisoning which started out as family fun on a spring 
holiday, continued on three hospitals and ended up putting new twists on a 
classic poisonous plant's pharmacognosy and clinical toxicology. 
 
Acknowledgements: Javid Hussain and Ulf Göransson, Division of 
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Westberg, Swedish Poison Information Center, did the follow-up with the 
poisoned family. 
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Extreme structure determination 
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The process of structure determination of complex natural products faces a 
number of possible challenges. In this presentation, a number of examples will be 
discussed with the natural products in question having been derived from 
different extreme environments such as deep oceans, cold seas and arid 
environments. The structures of these molecules are also extreme in different 
ways and require tailored solutions to define their structures. The examples 
discussed present difficulties in defining their stereochemistry, have too few 
hydrogens compared to the number of heavy atoms, or simply be very large 
(3600 MW). Strategies that will be presented to solve such problems include the 
use of computer simulations, atomic force microscopy and the combined use of 
genetics and spectroscopic techniques. 
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The quest for large amounts of Thapsigargin 
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Since 1978 when Ulla Wagner Smitt together with Søren Brøgger Christensen 
discovered Thapsigargin in the roots of Thapsia garganica L. the tale has moved 
forward [1]. Today a cancer drug based on Thapsigargin is progressing through 
clinical trials and GenSpera Ltd will market the drug under the generic name 
Mipsagargin [1]. Few have attempted to cultivate Thapsia garganica and 
currently only the company ThapsIbiza is working on this. With some success 
though it remains to be shown whether these cultivated species contain 
Thapsigargin. This is ongoing in our laboratory in collaboration with ThapsIbiza 
and as part of the EU project MedPlant (www.medplant.eu). Secondly, in the EU 
project DrugTissueCult (www.drugtissuecult.eu) we will attempt to use tissue 
culture systems to produce biomass of Thapsia garganica; this is performed in 
collaboration with Alkion Biopharma in France. 
 
The third approach is the elucidation of the biosynthesis of Thapsigargin 
(www.spotlight.ku.dk) and the product in a heterologous host. Here we published 
the first step of the pathway in 2012 [2], and can now present the second step. 
The first step was biosynthesized by a terpene synthase to yield kunzeaol, 
whereas the following step is mediated by a cytochrome P450. This step 
establish the lactone ring, and provide the backbone for further modifications. 
Further steps are currently being elucidated, and we will try to express these in 
yeast and the moss Physcomitrella patens. 
 
 
Acknowledgements: The work was supported by: SpotLight, a grant from the 
Danish Council for Strategic Research; DrugTissueCult, a Marie-Curie ITN-EID 
project funded from European Union's Seventh Framework Programme 
FP7/2007-2013/ under REA grant agreement n° [607011]; MEDPLANT, a Marie 
Curie Actions Initial Training Network (ITN), funded by the European Union under 
the Seventh Framework Programme FP7/2007-2013. 
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Sialidase enzyme as a novel drug target 
against trichomoniasis  
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Trichomoniasis is one of the most common sexually transmitted diseases with 
the prevalence rates of 15 % or higher among women in many developing 
countries [1]. It is caused by unicellular protozoan parasite Trichomonas vaginalis. 
Our current project is devoted to the investigation of one sialidase enzyme, 
acquired by T. vaginalis via lateral gene transfer from bacteria [2], as a target for 
drugs against trichomoniasis and to the discovery of natural compounds with 
inhibitory activity. 
 
The sialidase encoding gene from T. vaginalis was cloned into pLEXY-invitro2 
plasmid and translated into GFP-coupled protein using cell-free protein 
expression kit based on Leishmania tarentolae (Jena Bioscience GmbH, Jena, 
Germany). Expression of the protein and following enzymatic activity confirmation 
was monitored using fluorescence correlation spectroscopy.  
 
We have confirmed that the LEXY cell-free protein expression system functions 
for sialidase enzyme expression and that sialidase-GFP has a reduced diffusion 
coefficient compared to GFP alone, as expected due to the larger size of 
Sialidase-GFP. In the next step, we have analysed the enzymatic activity of 
sialidase by monitoring the catalysis of the substrate provided in the 
Neuraminidase Activity Assay Kit (Sigma-Aldrich, St. Louis, MO) into a 
fluorescent product. Potential inhibitors of expressed trichomonas specific 
sialidase enzyme among natural products will be further investigated. 
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Phylogenetic exploration of medicinal plant diversity.  
Can the evolutionary history of plants help guide  
better healthcare, new leads, and sustainable use  
of medicinal plants? 
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The use of plants for medicine is closely associated with human culture and has 
provided both local healthcare and new leads. Through evolution plants have 
developed sophisticated chemical defenses, which may explain their bioactivity in 
humans. Intuitively, the evolutionary history of plants may enable predictive 
approaches allowing systematic evaluation of current and potential medicinal 
value as well as help guide safety, conservation policies and agriculture. Recent 
studies by our group [1-3] and others [4], have highlighted that medicinal use, 
plant defensive compounds and bioactivity are correlated with phylogeny, but the 
predictive power of phylogenies is yet unknown. Developing new systematic and 
integrative approaches and tools to synthesize and take advantage of phylogeny, 
bioinformatics, ethnobotany, natural products, chemistry and bioactivity studies 
could supplement traditional selection approaches with the ultimate aim of 
providing better healthcare. This presentation will summarize recent studies, 
current efforts, and future directions as well as introduce the MedPlant 
International Training Network (www.MedPlant.eu) educating 15 young scientists 
in phylogenetic exploration of medicinal plant diversity. 
 
 
Acknowledgements: The research leading to these results has received funding 
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The peptide SunFlower Trypsin Inhibitor-1 (SFTI-1) is produced in the seeds of 
sunflower (Helianthus annuus). It comprises 14 amino acids and is characterized 
by a bicyclic structure due to the presence of a head-to-tail cyclized backbone 
and one disulfide bond, which together provide a remarkably stable structure [1]. 
SFTI-1 is as the name suggests a potent inhibitor of trypsin and in addition has 
been shown to be a promising scaffold for drug design in that the sequence can 
be modified to incorporate and stabilise other bioactive epitopes. Biosynthetically 
SFTI-1 is produced from a precursor for an albumin seed storage protein named 
PawS1. PawS1 is post-translationally processed by an aspariginyl endopeptidase 
into a mature two-chain albumin, and during this process SFTI-1 is cleaved out 
and cyclized [2].  
 
Recent work has provided insights into the evolution of SFTI-1. Genetic and 
liquid chromatography mass spectrometry based screening approaches of an 
additional 273 species in the family Asteraceae have identified a number of cyclic 
and acyclic peptides, with structural and sequence homology to SFTI-1. These 
are referred to as PawS-Derived Peptides (PDPs) [3]. Here we have used 
solution NMR spectroscopy to characterize the 3D structures of a number of 
PDPs showing that in general they form well-defined, rigid structures with a 
diverse range of folds as a result of their different sequences. The closest 
relatives of SFTI-1 are able to inhibit trypsin, however, no biological significance 
has yet been described for the more structurally diverse peptides. 
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Sponge taxonomy 2.0 meets pharmacognosy 
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Proper species identification and classification is crucial to any scientific study. 
Naming a species and using a proper classification is the only way to make sure 
that scientists are studying the same entity, and that all the data linked to 
conspecific specimens but produced by different researchers can be understood, 
associated and compared. Linking biological data (molecular, morphological, 
biochemical, ecological) to an incorrect species name or to no species name will 
result in these data losing tremendous value. This is an important issue in the 
field of sponge natural products since 1) the biodiversity of sponges is still poorly 
known and since 2) sponge taxonomy has been very unstable in the last decades. 
In the past 13 years, the classical taxonomy has been considerably overturned 
by an increasing number of molecular phylogenetic studies, with numerous 
polyphyletic groups revealed or confirmed and new clades discovered. Based on 
these results, Morrow & Cárdenas [1] now propose a revised classification of the 
Demospongiae, hoping to convince end-users to 1) abandon the use of artificial 
groups, and to 2) use the new/resurrected names proposed here when referring 
to the new Demospongiae clades. This updated classification will undoubtedly 
facilitate communication between end-users, reduce taxonomically biased results, 
and ultimately provide a better understanding of Demospongiae biochemistry and 
evolution. 
In this talk I will illustrate with previous studies and others from my current 
research how this new revised classification can shed a new light on previous 
and current sponge natural product and chemical ecology studies. 
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Bacterial biofilms are highly tolerant to most available antibacterial treatments, 
including various kinds of chemotherapy and host cell responses. A challenging 
problem is caused by biofilm involvement in nosocomial infections, which will 
continue rising due to the increasing use of indwelling medical devices [1]- Thus, 
an enormous need exists to meet the demands of novel effective anti-biofilm 
therapy.  
 
In this study, a library of Cinchona-alkaloids, including the natural compounds 
cinchonidine and cinchonine, as well as various synthetic derivatives was 
screened for antibacterial and anti-biofilm activity against Staphylococcus aureus. 
To evaluate the anti-biofilm activity of the compounds an assay platform including 
two staining methods, resazurin and crystal violet, was used to measure biofilm 
viability and total biomass, respectively. Also, the effect on planktonic bacteria 
was measured. Cinchonidine was found to be inactive, whereas interestingly, a 
synthetic derivative, 11-TPSCD (structure depicted), was effective against 
planktonic bacteria as well as in preventing biofilm formation at low micromolar 
concentrations [2]. Higher concentrations were required to eradicate pre-formed 
biofilms. The chemical space of these derivatives was also mapped using 
ChemGPS-NP [3,4] together with chemically-related quinolones antibiotics. The 
results show another ”priviledged” region for quinine-related molecules outside of 
the one populated by the quinolones antibiotics, which is worth exploring in future 
drug discovery strategies. 
 
Acknowledgements: This contribution is dedicated to the memory of Dr. Igor 
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acknowledged.  
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A new biological tool for disulfide-rich cyclic peptide 
synthesis: Application of PatG macrocyclase enzyme in the 
synthesis of cyclotides and sunflower trypsin Inhibitor-1 
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Circular peptides with disulfid bonds (cyclotides and SFTI-1) have created a great 
interest in the development of peptide-based drugs due to their improved 
physicochemical properties [1, 2, 3]. However, the most commonly used method 
for the head-to-tail cyclization of peptides has been native chemical ligation, [4] 
providing peptides with considerable purity and yields. However, the exposure to 
chemicals and costs associated with chemical synthesis drive the continuous 
search for novel methods for circular peptide synthesis [5]. A subtilisin-like 
macrocyclase called PatGmac produced by the cyanobacteria Prochloron sp. 
that are symbionts of the sea squirt Lissoclinum patella was identified in a recent 
study [6]. The PatGmac recognizes the C-terminal macrcyclization signature 
(positions P1’-P4’) AYDG, which is subsequently cleaved off to form a head-to-
tail cyclized peptide [6]. Here, we demonstrated that linear SFTI-1 precursor with 
a C-terminal AYDG enzyme recognition sequence could be efficiently cyclized by 
recombinant PatGmac macrocyclase mediated cyclization. Our findings provide 
proof-of-concept of the potential broad applicability of PatG enzymatic cyclization 
of disulfide rich peptides in drug development.  
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It has long been hypothesized that plant-derived natural products, responsible for 
many pharmacological effects in humans, form a mirror image of evolutionary 
relationships of plants producing them [1]. Several studies [2–5] have thus 
proposed a systematic approach for drug discovery from natural products 
inferring bioactivity due to reported uses in ethomedicine and making predictions 
about bioactivity of ethnomedicinally unknown species based on their 
phylogenetic relationships. To allow statistical analysis, described ethnomedicinal 
uses are classified into disease categories (often describing diseases associated 
with certain body parts), a common practice in ethnomedicinal research [6]. In the 
present study we propose an alternative classification system of ethnomedicinal 
uses based on molecular disease mechanisms as understood by most recent 
medical research and suggest that those are more closely related to the chemical 
nature and thus bioactivity of the natural products contained in plants and are 
therefore more appropriate for studies using phylogeny as a predictive tool in 
drug discovery. Using the extremely species-rich (~2000) [7] and almost 
cosmopolitan genus Euphorbia, known for its immunomodulatory diterpenes [8], 
we illustrate the impact different classification systems have on subsequent data 
interpretation. Our study shows that a classification system based on molecular 
disease mechanism providing a link between pharmacological properties and 
medicinal effects of plant-derived natural products, allows a more targeted 
approach for future biodiversity-driven drug lead discovery. 
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Hohmann, J. (2014) Chem. Rev. 114: 8579-8612.  
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High-resolution bioactivity profiling combined with hyphenated 
HPLC-HRMS-SPE-NMR for accelerated identification of  
bioactive natural products directly from crude extracts 
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Nature is a rich source of bioactive constituents, but traditional bioactivity-guided 
fractionation is a time-consuming and laborious task involving several 
preparative-scale chromatographic steps. In recent years, the hyphenation of 
analytical-scale high-performance liquid chromatography and high-resolution 
mass spectrometry with solid-phase extraction and nuclear magnetic resonance 
spectroscopy, i.e., HPLC-HRMS-SPE-NMR, has proven successful for full 
structure elucidation directly from crude extracts without any prepurification steps 
[1]. This even includes acquisition of direct-detected 13C NMR spectra, database-
assisted NMR structure elucidation and off-line assessment of circular dichroism 
spectra for assignment of absolute configuration. However, the basic HPLC-
HRMS-SPE-NMR setup does not give any information about the bioactivity of 
individual constituents in the crude extract. Thus, the recent coupling of 
microplate-based high-resolution bioassays with HPLC-HRMS-SPE-NMR, i.e., 
HR-bioassay/HPLC-HRMS-SPE-NMR, represents one of the most promising 
new developments for advancing research in bioactive constituents from natural 
sources like food [2], traditional medicine [3], plants [4], and microorganisms [5].  
 
A schematic illustration of the workflow in the HR-bioassay/HPLC-HRMS-SPE-
NMR analysis is given overleaf - and involves i: analytical-scale separation(s), ii: 
micro-fractionation into 96-well microplates, iii: bioassaying (e.g., aldose 
reductase, α-glucosidase, and ABTS•+ reduction), iv: results from bioassays 
plotted against their respective retention time to produce high-resolution 
biochromatogram(s), v: identification of bioactive analytes from biochromatogram, 
vi: HPLC-HRMS-SPE-NMR analysis targeting bioactive constituents, and vii: 
structural identification of bioactive constituents. In this talk some recent 
examples of the successful use of high-resolution bioactivity profiling in 
combination with HPLC-HRMS-SPE-NMR analysis will be given. 
 
References: 1. Staerk, D. et al. (2009) Phytochemistry 70: 1055-1061. 2. 
Kongsted, K.T. et al. (2015) J. Agric. Food Chem. 63: 2257-2263.  3. Liu, B. et al. 
(2015) J. Nat. Prod. 78: 294-300. 4. Kongsted, K.T. et al. (2014) J. Agric. Food 
Chem. 62: 5595-5602. 5. Wubshet, S.G. et al. (2013) J. Chromatogr. A. 1302: 
34-39.  
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Polyacetylenes from carrots (Daucus carota) with  
potential antidiabetic effects  
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Type 2 diabetes (T2D) is a metabolic disorder that is characterized by 
hyperglycemia in the context of insulin resistance and relative lack of insulin. T2D 
is currently treated with a combination of diet restriction and oral drugs. In a 
previous screening study a dichloromethane (DCM) extract of carrot roots was 
found to stimulate insulin-dependent glucose uptake (GU) in adipocytes in a 
dose-dependent manner [1]. Bioassay-guided fractionation of the DCM extract 
resulted in the isolation of the polyacetylenes falcarinol and falcarindiol, which 
both significantly stimulated basal and/or insulin-dependent GU in 3T3-L1 
adipocytes and porcine myotubes in a dose-dependent manner. Insulin 
sensitizing drugs such thiazolidinediones (TZDs) may cause severe side effects, 
which have been linked to their behaviour as full agonists of peroxisome 
proliferator-activated receptor (PPAR)γ [2]. Partial PPARγ agonists are 
associated with fewer side effects, although they maintain their effect on insulin 
resistance. Falcarindiol increased PPARγ-mediated transactivation significantly 
at concentrations of 3, 10 and 30 µM, while PPARγ-mediated transactivation by 
falcarinol was only observed at 10 µM but partially for both compounds 
compared to the TZD rosiglitazone. Docking studies accordingly indicated that 
both polyacetylenes exhibit characteristics of PPARγ partial agonists. Falcarinol 
was shown to inhibit adipocyte differentiation as evident by gene expression 
studies and Oil Red O staining, whereas falcarindiol did not inhibit adipocyte 
differentiation, which indicates that these polyacetylenes have distinct modes of 
action. The results of the present study suggest that falcarinol and falcarindiol 
may represent scaffold for novel partial PPARγ agonist with possible antidiabetic 
properties. 
 
References:  
1. El-Houri, R. B. et al. (2014) Evid. Based Complement. Alternat. Med. 
2. Berger, J. P. et al. (2003) Mol. Endocrinol., 17, 662−676.  
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Notes on chemical property position of bedaquiline  
construed by chemical global positioning  
system-natural product (ChemGPS-NP). 
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Bedaquiline represents both a novel chemical class of diarylquinolines and a 
novel mechanism of action against tuberculosis. It is one of the rare discoveries 
that have many clinically desirable properties. Thus quickly establishing a new 
paradigm for treatment of tuberculosis. Ranking of similarity and dissimilarity is of 
particular interest in lead discovery and compound optimization. Discrimination of 
bedaquiline is critical due to the fact that bedaquiline has a different mechanism 
of action from the relatively similar chemical structures.  
A new approach using eight scores of principle component analysis (PCA) 
provided by ChemGPS-NP has been employed to study the chemical property 
position of bedaquiline. The results were refereed as accumulative Euclidian 
distance for different antituberculosis sets and ChemGPS-NP was compared with 
extended connective finger-prints and Molecular ACCess System showing 30% 
and 182 % increase in accumulative Euclidian distance respectively. Potentially 
similar compounds from publically available anti-tuberculosis compounds and 
Maybridge sets based on bedaquilines eight dimensional similarity and different 
filtrations, were determined and provided as a contribution towards the 
challenging anti-tuberculosis drug discovery research. 
 
 
 
Figure 1. Position of bedaquiline (large pink sphere), 100 closest antituberculosis 
compounds (small spheres) and quinoline compounds (green spheres) by 
ChemGPS-NP where PC1 (x=red), PC2 (y=yellow) and PC3 (z=green).  
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Immunolocalization of cyclotides in plant cell, tissue 
and organs supports their role in plant defense  
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Premise of the study Cyclotides are cyclic plant peptides with a wide range of 
reported biological activities. Their role in plant defense has been suggested on 
the basis of insecticidal properties [1]. The tissue distribution of a defense 
compound may suggest type of pathogen it protects a plant from [2]. 
 
Methods Antibodies were raised in rabbit using the bracelet cyclotide 
cycloviolacin O2. Slides for immunohistochemistry were prepared from leaf, 
petiole and root fragments of Viola odorata, V. uliginosa and from plants known 
to not produce cyclotides (Arabidopsis thaliana and Nicotiana benthamiana) 
using procedure described before [3]. Visualization of specimens was performed 
using indirect epi-fluorescence microscopy. 
 
Antibodies were proven to be specific against bracelet cyclotides, abundant in 
Viola odorata. High relative amounts of cyclotides were found in leaf epidermis, 
and in the epidermis of petioles, in both Viola species. Cyclotides were also 
found in vasculature tissue (phloem) in all the assessed plant organs. Double 
immunostaining clearly indicated vacuolar storage of cyclotides.  
 
 
Acknowledgements: This work was funded in part by Ahlquists Stiftelse 
(Ahlquist Foundation) grant for research exchange at the Faculty of Pharmacy, 
Uppsala University; the Swedish Research Council (2012-5063); the Swedish 
Foundation for Strategic Research (F06-0058) (Ulf Göransson) 
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Zanthoxylum heitzii, a possible anti-malaria medicine 
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The Central African plant Zanthoxylum heitzii is used by traditional healers 
against malaria. We have found that the hexane bark extract is active against 
adults of the mosquito Anopheles gambiae, a vector for malaria transmission [1], 
and that this is mainly due to its content of the amide pellitorine. Admixture with 
other, inactive constituents of the extract increases the activity of the amide. 
Pellitorine also kills A. gambiae larvae. In addition, the extract is toxic to the 
malaria protozoa Plasmodium falciparum. In this case, the alkaloid 
dihydronitidine seems to be the main factor for toxicity. Neither of these 
compounds have been reported from this plant previously. Eight other 
substances have been isolated and identified. Seven of these are new to the 
plant, and one, the alkaloid heitziquinone, is a new natural product. From these 
investigations, it would seem possible that the traditional use of Z. heitzii against 
malaria may have a rational basis. 
 
Reference: 
1.Overgaard, H.J., Sirisopa, P., Mikolo, B., Malterud, K.E., Wangensteen, H., Zou, 
Y.F., Paulsen, B.S., Massamba, D., Duchon, S., Corbel, V., Chandre, F. (2014) 
Molecules 19: 21276-21290 
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Open Innovation and Data Integration - from docking  
poses to prediction of side effects 
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Within the past decade the way which computational drug design is conducted 
changed dramatically. With the availability of ChEMBL, PubChem, and 
ChemSpider, cheminformatics gradually moves to open access. One of the 
current major challenges is the integration of all these public data sources in 
order to allow targeting complex research questions, such as “give me all 
oxidoreductase inhibitors in humans an mice with an IC50 value <100 nM”. 
Semantic data integration platforms such as the Open PHACTS Discovery 
Platform not only enable to query across multiple data domains, they also open 
hitherto unreached possibilities for in silico model generation and model 
validation [1]. 
 
Within this talk we will present case studies for validating docking poses by 
ligand-based structure-activity relationships [2,3], for creating predictive 
classification models for transporters by mining public data bases [4], and for 
predicting side effects based on ligand-receptor interaction profiles [5]. 
 
Acknowledgements: We acknowledge financial support provided by the 
Austrian Science Fund (F3502) and the Innovative Medicines Initiative (Open 
PHACTS, 115191) 
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fungus Granulobasidium vellereum. 
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Granulobasidium vellereum is a wood-decomposing basidiomycete fungus that 
arrives at dead trunks of fallen hard wood trees at a late stage of the 
decomposition process. Thus, the fungus needs to out-compete the organisms 
already colonizing the site. It was hypothesized that part of the fungus 
competitive ability was based on the production of secondary metabolites. 
Consequently, the production of the secondary metabolites by this fungus was 
investigated. 
 
In total, 33 secondary metabolites, all of sesquiterpenoid origin, were isolated 
from fungal cultures by chromatographic methods and characterized by 
spectroscopic techniques [1-3]. Twenty-two of these compounds were previously 
not described, and two were new as natural products. Only one of the 
compounds displayed potent antifungal activity, whereas five of the isolated 
compounds were highly cytotoxic.  
 
When cultivated together with other wood-decay fungi, the production of 19 
metabolites from G. vellereum were up-regulated in all studied interactions, 
whereas several other compounds were up-regulated in individual interaction 
cultures [4].    
 
References: 
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Bio-guided fractionation of immunomodulatory compounds 
from the marine sponge Halicondria sitiens. 
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Iceland has a unique position in the North Atlantic Ocean where geothermal heat 
and cold water masses meet. Despite this unique environment, marine natural 
products have only been investigated to a limited extent with regard to chemical 
constituents of pharmacological interest. The aim of this study was to collect 
sponges at marine hydrothermal vent sites, prepare extracts and test their 
immunomodulatory effects in a human monocyte-derived dendritic cell (DC) 
model (1) and to use bio-guided isolation to identify new compounds with anti-
inflammatory potential. The maturation of DCs in the presence of an organic 
extract of the sponge Halicondria sitiens at 100 µg/ml resulted in lower secretion 
of the cytokines IL-10 and IL-12p40 and a lower ratio of IL-12p40/IL-10 in 
comparison with DCs matured without the extract. This pattern of response 
indicated reduced inflammatory capacity of the DCs. The extract was separated 
into fractions using various chromatographic methods (i.e. CC, VLC, SPE and 
preparative HPLC) followed by TLC, 1H-NMR and LC-MS/MS. At each step in 
the bio-guided isolation procedure the fractions were tested for activity in the DC 
model. Eight of the fractions showed significant immunomodulatory effects and 
two of them almost completely hindered IL-12p40 secretion. The two fractions 
with the most immuno-modulatory effects also caused morphological changes of 
the DCs. None of the active fractions were cytotoxic. The final steps of the 
isolation of pure compounds and their structure elucidation (NMR, MS/MS) are in 
progress. These results indicate the presence of new immuno-modulating 
compound(s) in H. sitiens but to our knowledge no compounds have been 
described from this species. 
 
Acknowledgements: Doctoral grant and project grant of The University of 
Iceland Research Fund; Project grant from the Ministry of Fisheries and AVS 
R&D Fund of Ministry of Fisheries and Agriculture in Iceland; Project grant from 
Landspitali University Hospital Research Fund. 
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Central-stimulating and analgesic activity of the ethanolic 
extract of Alternanthera sessilis in mice  
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Alternanthera sessilis is a popular vegetable and used in traditional medicinal 
practice of Bangladesh and other parts of Asia to relive tiredness, laziness, and 
sleeps as well as pain and inflammation [1]. However, no report was found on the 
neuropharmacological and analgesic activity of this plant to-date. Present study 
was undertaken to evaluate the neuropharmacological and analgesic activity of 
the ethanol extract of A. sessilis whole plant (ETAS) in mice models. Central 
stimulating activity was investigated by pentobarbitone induced sleeping time, 
open field, and hole cross tests. Analgesic activity was evaluated by acetic acid 
induced writhing and hot-plate methods. The tests were performed at 250 and 
500 mg/kg body weight dose levels. In sleeping time test, ETAS significantly (p < 
0.001) increased the onset of sleep, and decreased the duration of sleep. In open 
field and hole cross tests, ETAS significantly (p < 0.001) increased the 
movements of mice which persisted throughout the study period. In writhing test, 
ETAS showed, significant (p < 0.001) inhibition of writhing reflex. In hot plate test, 
ETAS significantly (p < 0.001) raised the pain threshold. In HPLC analysis for 
polyphenols, (+)-catechin, rutin, ellagic acid, and quercetin were detected in 
ETAS (117.72, 490.74, 3007.26, and 13.85 mg/100 g of dry extract, respectively). 
Present study supported the traditional uses of A. sessilis and indicated that the 
plant can be a potential source of bioactive molecules. 
 
Acknowledgements: Khulna University Research Cell, Khulna, Bangladesh 
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Ligand fishing using functionalized magnetic beads  
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α-glucosidase inhibitors in a crude plant extract 
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Screening complex plant extracts for new drug leads is a challenging task, and 
therefore advanced alternatives to classical bioassay-guided fractionation are 
needed. Among the advanced technologies introduced in recent years is ligand 
fishing, which is a technique where a selected therapeutic target (a receptors or 
an enzyme) is immobilized on a solid support. The solid support with the 
immobilized enzymes/receptors is then used to selectively fish out potential 
ligands from complex mixtures. In natural products, this technique has been used 
as a pharmacological profiling tool to discover biologically active metabolites in 
crude extracts. Ligand fishing has been utilized in combination with mass 
spectrometry - either by desorption ionization directly off the fishing probe [1] or 
through LC-MS after releasing the bound ligands into appropriate solvent [2]. 
Despite the successful implementation of mass spectrometry for analysis of 
biological concentrates prepared by ligand fishing, the limited structural 
information can hamper elucidation of novel ligands. Therefore, we present a 
combination of the ligand fishing technology with a one of the most powerful 
structural analysis tool, i.e. high-performance liquid chromatography - high-
resolution mass spectrometry - solid-phase extraction - nuclear magnetic 
resonance (HPLC-HRMS-SPE-NMR) [3]. In the current work, functionalized 
magnetic beads with the N-terminus bound α-glucosidase were synthesized and 
used as a ligand fishing tool to fish out potential anti-diabetic compounds from a 
crude plant extract. The HPLC-HRMS profile of the 'fished-out' concentrate was 
used to pinpoint the high-affinity ligands, which afterwards, were subjected to a 
targeted HPLC-HRMS-SPE-NMR analysis directly from the crude extract. 
 
Acknowledgements: The ligand fishing project is funded by The Danish Council 
for Independent Research | Technology and Production Sciences 
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Research in chemical ecology gives us knowledge about the fascinating diverse 
chemical communication that exists among organisms, including humans. The 
aim is to develop chemical tools for controlling insects and other organisms 
preventing diseases in animals and plants. Examples from our research of how 
we can utilize butterfly pheromones, fungi volatiles and conifer resin constituents 
for organic cropping and sustainable agriculture and forestry will be given. 
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Circular proteins are an important class of natural products, now described from 
all sources of life, including plants, animals, bacteria and fungi [1]. Inspired from 
nature’s repertoire of circular proteins, the concept of backbone cyclization is 
utilized to improve stability of many pharmaceutically important peptides [2]. The 
current work describes the use of sunflower trypsin inhibitor 1 (SFTI-1) scaffold, a 
14 residues disulfide stabilized circular peptide for incorporating bioactive 
epitopes that are relevant in the therapeutic context rheumatoid arthritis (RA) [2]. 
Autoantibodies highly specific for RA, known as anti-Citrullinated Peptide 
Antibodies (ACPAs), are not only prognostic markers of RA, but appear to play a 
key pathogenic role in RA disease progression itself [3]. Citrullination has been 
observed in different synovial proteins of RA patients including type II collagen, 
fibrinogen, α-enolase and vimentin. Although synthetic peptides that mimic the 
natural antigens of ACPA have the potential to block ACPA, the stability of such 
peptides is a major concern in their ultimate use in a biological context. By 
incorporating the citrullinated peptide epitopes within the stable SFTI-1 scaffold 
we have provided proof of concept that ACPA can be inhibited in vitro by stable 
peptides that mimic their natural antigen. Currently, the isolation of specific 
subtypes of ACPA and development of a patient tailored ELISA system to 
facilitate diagnosis of specific subtypes of ACPA unique to each patient profile is 
underway.  
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Fungal natural product chemistry in the genomic era. 
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With the entering into the Genomic Era the field of microbial natural product 
chemistry has changed dramatically in recent years. The number of available 
genomes are expanding exponentially. AT DTU we are currently involved in a 
genome sequencing project targeting all > 340 known species in genus 
Aspergillus. Fortunately the genes involved in biosynthesis of fungal secondary 
metabolites are located in clusters, setting the scene for bioinformatics driven 
analysis of the chemical potential of a given species. Surprisingly these types of 
analyses have shown that the number of clusters encoding secondary 
metabolism is much higher than the number of known compounds even in well-
studied model organisms. Consequently the potential for discovery of novel 
compounds from such cryptic gene cluster is still vast. 
This presentation will highlight the different approaches that we are undertaking 
at DTU to discover, characterize and engineer fungal biosynthetic pathways. This 
will include examples of: i) Genome wide deletion of all polyketide synthase 
genes in A. nidulans to clarify the biosynthesis of meroterpenoids; ii) 
Development of a novel algorithm for analysis of transcription data to link 
distantly located but co-expressed genes to discover novel prenylated non-
ribosomal peptides; iii) How deletion of all genes involved in the 6-methyl-
salicylic acid derived biosynthetic pathway has led to many novel yanuthones; iv) 
How induction of sclerotium formation stimulated expression of previously 
silenced genes and led to novel chemistry; v) Examples of how overexpression 
of transcription factors can boost biosynthetic pathways and even stimulate 
chemistry across different pathways. 
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The unique organisms living in the world’s oceans are an inspiring source of new 
pharmaceutical leads. To date, some 13 drugs of marine derivation or inspiration 
have reached the clinic in the US, Europe or Asia, and many more are on the 
horizon. In this regard, we have focused our investigations on the bioactive 
metabolites available from marine cyanobacteria and algae, both groups of which 
are extraordinarily rich in structurally diverse natural products.  Moreover, we are 
exploring the integrated use of several different technologies, such as genome-
based information, mass spectrometry-based Molecular Networks, and synthetic 
medicinal chemistry, to innovatively discover and develop new drug leads from 
these marine organisms. For example, a Curaçao collection of a tuft-forming 
cyanobacterium, Symploca sp., possessed an extract that was highly cytotoxic to 
several different cancer cell lines.  A combination of a bioassay and NMR guided 
isolation process yielded two compounds, named carmaphycin A and B, which 
were responsible for the potent activity.  We are exploring their utility as potential 
anticancer agents through a variety of orthogonal approaches. Another recent 
project involves a new approach that integrates genomic and metabolomic 
information to identify structurally novel and biologically active metabolites.  This 
latter work identified a series of novel chlorinated acyl amides that have potent 
binding properties to cannabinoid receptors. By integrating several different and 
contemporary approaches, new vistas in the natural products sciences are being 
revealed. 
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Royal jelly (RJ) has been widely used as a popular and traditional food for health 
promotion. RJ is rich with bioactive constituents such as 10-hydroxy-2-decenoic 
acid, jelleines, and major royal jelly proteins (MRJPs) considered as anti-cancer 
and anti-bacterial agents [1,2] as well as royalisin, well-known as anti-bacterial 
agent against gram-positive bacteria [3,4]. The complete identification of RJ 
complex composition is a research issue that remains quite open, and the 
development of new characterization techniques is allowing the discovery of new 
compounds.  
The enzymatic hydrolysis method is one of the most preferred methods in the 
food and pharmaceutical industries over the other methods, which could leave 
the organic residues or toxic chemicals in the products. The released peptides 
from enzymatic hydrolysis are exert various physiological as antioxidant [5] and 
anti-hypertensive [6]. For the first time we identified the antimicrobial peptides 
from RJ hydrolyzate using mass spectrometry analysis with aid of Mascot, NCBI 
databases. The peptides were screened against four pathogens including; 
Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa and Candida 
albicans [6].  
Taken together, Bioassay guided fractionation for RJ hydrolyzate using RP-HPLC 
lead to isolate for three peptides with promising antimicrobial activity. More 
detailed studies are required to explore their possible future applications in 
functional food and/or pharmaceuticals industry [7]. 
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Antibacterial activities were detected in six bacteria strains obtained from soil 
samples. One strain designated as A-4 produced an inhibitory substance, which 
was active against number of Gram-positive bacteria as well as clinical isolates. 
The strain was identified as Bacillus subtilis by standard microbiological and 
biochemical tests. Total secondary metabolites compounds isolation was 
performed. A total of 16 secondary metabolites were identified along with 
lipopeptide. Identified as hexa-lipopeptide with a mass of 1230 Da. The later did 
not lose its activity on treatment at different pH values, temperatures and 
enzymes. The pronounce activity against multidrug resistant clinical isolates and 
the favorable biochemical properties of this peptide from the newly isolate strain 
suggest a new and effective agent against resistance in pathogenic microbes 
  
	  81 
P03 
 
Common deviation screening: A targeted approach for  
novel metabolite discovery using common molecular  
formula deviations and high resolution mass spectrometry. 
 
A. J. C. Andersena, S. A. Rasmussena, P. J. Hansenb,  
T. Ostenfeld Larsenb, K. Jørgensenc, and K. Fog Nielsena 
 
aSystems Biology, Technical Univ. of Denmark, Lyngby, Denmark.  
bMarine Biological Section, Univ. of Copenhagen, Helsingør, Denmark. 
cNational Food Institute, Technical Univ. of Denmark, Søborg, Denmark. 
 
The discovery of novel and/or bioactive natural products is often a difficult and 
time-consuming process. In some cases, where chemistry of an organism is 
previously known, dereplicating known compounds is vital for highlighting 
potentially unknown metabolites [1]. In some instances little is known of the 
chemistry of a target species, and the vast majority of the chemical features 
observed in a chromatogram are unknown. A chromatogram produced by high 
resolution mass spectrometry of a crude algae extract can easily contain over 
1000 unknown molecular features making the identification of a metabolite target 
difficult. This is particularly evident in algae, which produce chlorophyll 
metabolites that, along with their degradation by-products, complicate spectra. 
Although there may be little known about a particular species of algae, when 
considering algae as a whole many toxins have been characterised [2]. From 
certain species, classes of toxins have been characterised, such as the 
karlotoxins from Karlodinium veneficum [3]. One thing that many algae metabolite 
classes have in common is that they are typically large polyketides, often 
containing multiple ether rings. Due to structural similarities between metabolite 
classes, structural differences within classes can be summarised and applied to 
metabolites of other species to generate a list of over 1000 hypothetical 
molecular formulas within seconds. This list can then be used to screen a 
chromatogram, identifying a potential target metabolite within a few minutes. 
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Natural Products (NPs) are “privileged structures” that have inspired the design 
of many approved drugs. In the light of their importance, in silico tools aimed to 
explore the chemical space defined by NPs have been developed.  
ChemGPS-NP is a global chemical positioning system for the exploration of 
biologically relevant chemical space and represents an extension of the previous 
ChemGPS model by addition of Natural Products [1,2]. This global space map is 
based on 35 physico-chemical properties; the resulting multidimensional data is 
simplified through a Principal Component Analysis (PCA) in 8 dimensions 
describing the variance of the physico-chemical properties. Molecules with known 
chemical structures can be projected in the ChemGPS map and resulting 
properties can be compared with other molecules. An important concept in 
medicinal chemistry is the relationship between similarity of structural features, 
physico-chemical properties and biological activity. In other words, similar 
molecules are likely to present similar biological properties [3]. In this perspective, 
the location of a molecule in the ChemGPS-NP space can be used to predict its 
biological profiles by analyzing the biological activities of the surrounding 
molecules.  
In this work, we challenged ChemGPS-NP for the ability to retrieve the bioactivity 
of candidate compounds, when compared to reference sets gathered from 
ChEMBL collection [4]. We also analyzed the complementarities between the 
description of molecular similarity using ChemGPS-NP and a fingerprint-based 
method (based on ECFP_4) [5]. Finally, we applied these approaches to 
investigate the similarity of Natural Products to known bioactive compounds.  
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Pandanus amaryllifolius Roxb. (Pandanaceae) is a tropical shrub distributed in 
Southeast Asia and used as a flavor and folk medicine as a remedy for the 
treatment of hyperglycemia, liver protection, and inhibition of tumor growth. The 
ethanolic crude extract of P. amaryllifolius aerial part showed potential 
antioxidant, anti-biofilm, and anti-inflammatory activities. The purification of the 
ethanolic extract yielded nine new compounds, including two 
norpandamarilactonines, norpandamarilactonine-C (1) and -D (2), two 
indolizinones, pandalizine-A (3) and -B (4), a pandanamine, pandanamine-A (5), 
three pandamarilactones, pandamarilactone-2 (6), -3 (7), and -4 (8), and an 
unusual pandamarilactonine, pandalatonine (9).  
In the current study, the isolated alkaloids, with either γ-alkylidene-α,β-
unsaturated-γ-lactone or γ-alkylidene-α,β-unsaturated-γ-lactam system, can be 
classified into five skeletons of Pandanus alkaloids, including 
norpandamarilactonine, indolizinone, pandanamine, pandamarilactones, and 
pandamarilactonine. The structural elucidation and absolute configuration of 
these compounds are revealed in this investigation. Moreover, a plausible 
biogenetic pathway of Pandanus alkaloids 1–5, 7, and 9 is proposed. 
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Honeybee products have been used in traditional medicine for thousands of 
years, and there is an increasing interest in the applications in modern medicine. 
Bee products can have diverse biological activities as anticancer [1], 
antimicrobial [2], anti-oxidant [3], anti-inflammatory [4], antiviral and 
hepatoprotective [5]. Todays, there is an urgent call to find anticancer and 
antimicrobial agents from the natural products with less ecological damage and 
minimum health and environmental hazards. The nature, geography and weather 
of Egypt provide possibly a rich source of bee products and with the help of the 
scientific facilities in Sweden, diverse pharmaceutical leads can be discovered. 
Our main aim is to identify and characterize the bioactive peptides from bee 
products. These peptides have been poorly characterized, partly because they 
are generally present in trace quantities. Isolated active peptides from the bee 
products have been identified using techniques including High Performance 
Liquid Chromatography (HPLC), Mass Spectrometry (MS, LC/MS, MS/MS), 
Amino Acid Analysis (AAA) and 2D-Nuclear Magnetic Resonance Spectroscopy 
(2D-NMR). Polar fractionation prior to screening of anticancer and antimicrobial 
activities has been done.  
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61 species from 29 families of Egyptian medicinal plants were collected from the 
Sinai desert and documented. The native Bedouins relied completely on the 
natural products for their food and medication usage. The practice of traditional 
folk medication is as old as the community itself and the documentation is kept by 
local herbalists. The traditional uses of the Egyptian plants cover a wide range of 
medical conditions including cancer. The anti-cancer biological activity was 
investigated using a cytotoxicity assay against human lymphoma U-937 GTB. 
The most potent extracts were those from Asclepias sinaica, U. maritima, Nerium 
oleander and Catharanthus roseus. Literature reports indicate that several of 
these plants produce cardiac glycosides. Bioassay-guided fractionation of 
alcoholic U. maritima extracts led to the isolation of a bioactive bufadienolide that 
was subsequently shown to be proscillaridin A, as determined by 1D and 2D-
NMR spectroscopy [1]. Another important Egyptian medicinal plant is Adenium 
obesum. Bioassay-guided fractionation of steam extract leads to isolation of a 
novel cardiac glycoside compound named oleandrigenin-β-D-glucosyl-2`-O-
hydroxy-β-D-thevetoside (2`-O-hydroxy-obebioside B) with strong cytotoxic 
activity against human histiocytic lymphoma cell-line, U937-GTB. The structure 
was elucidated using intensive spectroscopic tools of UV, IR, 1D and 2D NMR in 
details, including TOCSY, HSQC-DEPT, and HMBC, and MS2. This result 
demonstrates the value of plants used in traditional medicine as sources of 
medicinally interesting cytotoxic compounds. The presentation concludes with a 
brief discussion on the integration of traditional medical knowledge into the 
existing literature as well as discovery of some classes of natural products in 
plant families. 
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Rheumatoid arthritis (RA) is a systemic inflammatory autoimmune disease 
primarily affecting synovial joints. Studies indicate that citrullination (the 
posttranslational deimination of arginine to citrulline) of peptides and proteins in 
synovial tissue play an important role in initiation of RA. The thus modifed 
proteins are recognized by pathogenic anti-citrullinated protein/peptide antibodies, 
so called ACPAs1. ACPAs are highly specific for RA patients with a sensitivity of 
76% and specificity of 96%2 and their presence in RA is associated with more 
aggressive disease. Citrullination have also been observed in various 
inflammatory diseases such as SLE, Sjögrens syndrome and fibrosis.  
The best characterized citrulline-containing peptides in RA are fibrin/fibrinogen, 
α-enolase, type-II collagen, vimentin and filaggrin, but selectivity and degree of 
citrullination differ between individuals. A set of linear truncated citrullinated 
peptide analogues based on the sequences above, have been synthesized for 
determination of ACPA selectivity. Inspired by stable cyclic peptides from natural 
origin and their potential to stabilize bioactive peptides3 we aim to develop 
selective ACPA-binding peptides for use as diagnostic tests or as ACPA-
neutralizing compounds. To that end, peptides will be selected for cyclization and 
insertion into scaffold sequences based on the results of affinity studies,. 
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Soil bacteria of the genus Streptomyces are renowned for their ability to produce 
various antibiotics and other bioactive secondary metabolites. The 
pyranonaphthoquinone (PNQ) type II polyketide class contains Streptomyces 
metabolites with a common biosynthetic origin and a fused three-ring aglycone 
unit consisting of a pyran, a quinone and a benzene ring.  
Some PNQ polyketides possess reported antibacterial activity against Gram-
positive species, including methicillin-resistant strains of the important pathogen 
Staphylococcus aureus, but the bioactivities of several recently isolated PNQs 
have not been previously explored. Furthermore, none of the PNQs have been 
specifically investigated for their anti-biofilm activity. In this study, the 
antimicrobial potency of the PNQs against both planktonic and biofilm cells was 
evaluated using redox dye-based viability staining, and the anti-biofilm efficacy 
was confirmed by viable counting. 
Unexpectedly, one of the most potent anti-biofilm PNQs was a pathway shunt 
product, which was more active against both planktonic cells and pre-formed 
biofilms than the pathway end product. The most active anti-biofilms were found 
to share several structural features related to glycosylation, charge and the 
oxygenation pattern of the aglycone unit.  
The findings suggest that effective anti-biofilms with optimized chemical 
structures may have co-evolved in Streptomyces spp. along with antibiotics.     
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Natural compounds, selected by evolutionary forces, provide an enormous 
reservoir of chemical diversity and a corresponding diversity of biological 
activities. Among them, sesquiterpene lactones (STLs) represent a large and 
diverse group of secondary plant metabolites with a wide range of biological 
activities. Mainly produced in Asteraceae, STLs are also found in other families of 
the angiosperm such as Magnoliaceae or Apiaceae [1]. 
A long-standing hypothesis in phytochemistry states that among more advanced 
groups of angiosperm one would find more advanced chemistry. To address this 
question, we investigated the correspondence between phylogenetic 
relationships and chemical diversity of a comprehensive ‘in-house’ dataset of 
STLs. 
In summary, we collected over 5300 compounds and analysed them through 
ChemGPS-NP, a tool to navigate chemical property space of natural products [2]. 
Based on Principal Component Analysis (PCA) it allows an efficient analysis and 
comparison of compounds based on their physical-chemical properties in 8 
dimensions. Through visualisation in the ChemGPS-NP global map, clusters and 
trends can easily be identified. 
By evaluating the distribution of STLs in chemical space, we identified different 
volumes and trends mirroring how STLs evolve during evolution, and analysed 
changes in physico-chemical properties in more evolved families. The results of 
this study support the above-mentioned hypotheses and lay the foundation for 
quantification and further exploration of the correlation between phylogenetic 
advancement of a taxon and chemical complexity by taking advantage of 
ChemGPS-NP visualisation. 
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The global herbal products market has grown in recent years, making regulation 
of these products paramount for public healthcare [1,2,3]. For instance, the 
common horsetail (Equisetum arvense L.) is used in numerous herbal products, 
but it can be adulterated with closely related species, especially E. palustre L. 
that can produce toxic alkaloids [4]. As morphology-based identification of these 
products is often difficult or impossible, the identification of processed material 
can be aided by molecular techniques [5,6].  
In this study, we explored two molecular identification techniques ability to test 
the purity of these products: a Thin Layer Chromatography approach (TLC-test) 
included in the European Pharmacopoeia and a DNA barcoding approach, used 
in recent years to identify material in herbal products. We tested the potential of 
these methods for distinguishing and identifying these two species using material 
from herbarium collections and commercial herbal products.  
We found that both methods could discriminate between the two species and 
positively identify E. arvense. The TLC-test is more cost- and time-efficient, but 
DNA barcoding is more powerful in determining the identity of adulterant species. 
Our study shows that, although DNA barcoding presents certain advantages, 
other established laboratory methods can perform as well or even better in 
confirming species’ identity in herbal products.  
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The common or broad-leaved plantain, Plantago major L., is a cosmopolitan 
weed known from every continent except Antarctica. The species was named 
“white man’s footprint” by the American natives because it flourished everywhere 
white people had been [1]. Despite its reputation as a worldwide weed, P. major 
has had a long history of medicinal use, primarily for its wound-healing properties. 
It continues to be used as a herbal remedy today, including in the introduced 
parts of its range [2,3].  
Caffeic acid esters, iridoid glycosides and polysaccharides are some of the 
compounds in the plant responsible for its anti-bacterial and anti-microbial activity 
[1,4,5]. The activity and uses of P. major have been well-studied, yet the role that 
geographic location or environment play on the types of chemicals produced by 
the species has not been thoroughly investigated, though there is some evidence 
that the chemical compounds produced by the plants vary geographically [4,5]. 
Due to its worldwide distribution and ability to grow in such a wide range of 
environmental conditions, P. major is a model species for exploring whether leaf 
chemical profiles are more restricted by genotype than by environment.  
Genetic and chemical fingerprinting, and habitat (soil type) parameters are being 
sampled from over 50 localities across the world to investigate patterns of 
chemotype diversity at a global scale. In addition, a phlyogeographic approach is 
being taken to map the migration routes of Plantago major from its putatively 
native origins in Europe and Asia to its current worldwide distribution.  
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Pueraria lobata is a perennial leguminous vine, which is widely distributed in 
China where it is used as a dietary supplement and herbal medicine due to its 
profound pharmacological functions [1]. P. lobata extract has previously shown 
antioxidant activity – one of the most important effects of functional food, dietary 
supplements and anticancer natural products – as well as α-glucosidase 
inhibitory activity – an important effect for managing blood glucose for type 2 
diabetics.  
The crude methanol extract of P. lobata was investigated by dual high-resolution 
α-glucosidase inhibition [2] and radical scavenging [3] profiling combined with 
hyphenated HPLC-HRMS-SPE-NMR [4]. Direct analysis of both major and minor 
constituents in the crude extract without preceding purification was facilitated by 
combining chromatograms from two analytical-scale HPLC separations of 120 
and 600µg on-column, respectively. High-resolution α-glucosidase and radical 
scavenging profiles were obtained after microfractionation of the eluate in 96-well 
microplates. This allowed full bioactivity profiling of individual peaks in the HPLC 
chromatogram. Subsequent HPLC-HRMS-SPE-NMR analysis allowed 
identification of 24 compounds of which several showed radical scavenging 
activity while two isoflavonoids showed α-glucosidase inhibitory activity. 
 
 
References: 1. Du, G. et al. (2010) J. Chromatogr., A 1217: 705-717. 2. Schmidt, J. et 
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Seven new lanostanoids, isolated from the sclerotia of Poria cocos, were 
elucidated to be: (20ξ)-16α-hydroxy-3-oxo-24-methyllanosta-5,7,9(11),24(31)-
tetraen-21-oic acid (1), (20ξ)-3β,16α,29-trihydroxy-24-methyllanosta-7,9(11),24 
(31)-trien-21-oic acid (2), (20ξ)-3β,16α,30-trihydroxy-24-methyllanosta-7,9(11),24 
(31)-trien-21-oic acid (3), (20ξ)-3β-acetyloxy-16α,24α-dihydroxy-lanosta-7,9(11), 
25-trien-21-oic acid (4), (20ξ)-5α,8α-epidioxy-3-O-hydroxyacetoxy-3β,16α-
dihydroxy-24-methyllanosta-6,9(11),24(31)-trien-21-oic acid (5), (20ξ)-3β,16α-
dihydroxy-7-oxo-24-methyllanosta-8,24(31)-dien-21-oic acid (6) and (20ξ)-3α, 
16α-dihydroxy-7-oxo-24-methyllanosta-8,24(31)-dien-21-oic acid (7), based on 
extensive spectroscopic analyses. The antileukemic activity of the new 
compounds (except 3 and 4), along with the fifteen known lanostane-type 
triterpenoids, was evaluated against four leukemic cell lines (Molt 4, CCRF-CEM, 
HL 60 and K562). Dehydropachymic acid (9), dehydroeburicoic acid (12), 
pachymic acid (14) and lanosta-7,9(11),24-trien-21-oic acid (20) exhibited 
cytotoxic effect on CCRF-CEM cancer cell line with IC50 values of 1.43, 2.96, 
2.61 and 5.96 µg/mL, respectively. Both dehydropachymic acid (9) and 
dehydroeburicoic acid (12) showed cytotoxicity against Molt 4 (IC50 7.26 and 
6.67 µg/mL) and HL 60 (IC50 3.84 and 2.79 µg/mL) leukemic cell lines. 
ChemGPS-NP analysis on the active lanostanoids from P. cocos suggested that 
targets other than topoisomerases may be involved in the cytotoxic effect. 
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Traditional Chinese medicines (TCMs) are widely used in the ethnic Chinese 
population. Recently, it has also been found that more Asian and non-Asian 
consumers and patients are using TCMs in the United States. The perception 
that natural substances are deemed safe has made TCM popular in the 
treatment and prevention of disease globally. However, such an assumption is 
often misleading owing to a lack of scientific validation.  
To assess the safety of TCM, in silico screening provides major advantages over 
the classical laboratory approaches in terms of resource- and time-saving and full 
reproducibility. To screen the hepatotoxicity of the active compounds of TCMs, a 
quantitative structure-activity relationship (QSAR) model was firstly established 
by utilizing drugs from the Liver Toxicity Knowledge Base. These drugs were 
annotated with drug-induced liver injury information obtained from clinical trials 
and post-marketing surveillance.  
The performance of the model after nested 10-fold cross-validation was 79.1%, 
91.2%, 53.8% for accuracy, sensitivity, and specificity, respectively. The external 
validation of 91 well-known ingredients of common herbal medicines yielded a 
high accuracy (87%). After screening the TCM Database@Taiwan, the world’s 
largest TCM database, a total of 6853 (74.8%) ingredients were predicted to 
have hepatotoxic potential. The one-hundred chemical ingredients predicted to 
have the highest hepatotoxic potential by our model were further verified by 
published literatures. Our study indicated that this model can serve as a 
complementary tool to evaluate the safety of TCM. 
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Cyclotides are a family of plant proteins with a cyclic backbone and three 
disulfide bonds that tie them into the so-called cyclic cystine knot. The extreme 
stability of cyclotides to chemical, thermal and enzymatic degradation makes 
them a promising scaffold for drug design applications [1]. We have previously 
shown that the cyclotide, cycloviolacin O2 (cyO2) has a killing effect on Gram-
negative bacteria in low micro-molar concentrations [2]. In the present study, we 
have explored the mechanisms of resistance development to cyO2.  
For this purpose, 14 independent lineages of Salmonella typhimurium and 4 
independent lineages of Escherichia coli were cycled in increasing 
concentrations of cyO2 for 150 cycles (900-1050 generations). Clones were 
isolated from the populations evolving under this selective pressure. Mutations 
identified by whole genome sequencing were involved in controlling diverse 
biochemical pathways. Genetic analysis of individual mutations confirmed the 
proposed mechanisms of resistance. Phenotypic characterization of these effects 
may hint about the mechanism(s) of action of cyO2. In addition, studies of fitness 
costs may provide data based on which rate and trajectory of evolution and 
spread of resistance can be predicted. 
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The use of colors is an important tool to increase the attractiveness of the food 
products. Among different colors used in food products, blue color is gaining 
more importance due to its unique appeal and psychological perception as 
trustworthiness of the product. Currently available blue colors on the market are 
produced by chemical synthesis, and recent reports have suggested that these 
colors induce allergic reactions among children [1]. In addition, there is growing 
perception among the consumers that natural colors are safe as compared to the 
synthetic ones. Therefore, there is a need for development of natural blue food 
color as an alternative to synthetic blue colors. 
Spirulina platensis is a cyanobacteria containing blue light harvesting proteins 
(phycocyanins) for photosynthesis. Recently, USFDA has approved the use of 
spirulina extract as a source of blue color; however, only for use in gums and 
candy. In addition to the limited use, the extract does not offer stable blue color 
shades comparable to the synthetic ones [2]. Aim of this work is to cleave and 
purify the chromophore, phycocyanobilin, from the phycocyanins present in the 
Spirulina extract. Different cleavage processes such as acid hydrolysis and 
methanolysis will be investigated and process parameters will be optimized. 
Intensification and stabilization of phycocyanobilin color is envisaged through co-
pigmentation. Naturally occurring non-colored compounds such as amino acids, 
phenolic acids, flavonols and dihydroflavonols will be screened as cofactors in 
co-pigmentation experiments. The possibilities of phycocyanobilin forming co-
pigment complexes with metal ions will also be investigated. Selected results of 
the work will be presented.  
 
References:  
1. European Food Safety Authority (2013) EFSA Journal, 11, 2818.  
2. Newsome, G. et al. (2014) J. Agric. Food Chem., 62, 6498−6511. 
  
	  96 
P18 
 
Multidisciplinary approach towards an economically viable 
isolation of natural products from plants:  
Example of artemisinin from Artemisia annua 
 
C. R. Malwade and L. P. Christensen 
 
Dept. of Chemical Engineering, Biotechnology and Environmental Technology,  
Univ. of Southern Denmark, Odense, Denmark. 
 
Several secondary metabolites from medicinal plants have been recognized as 
leading drug molecules. Traditional medicinal systems still continue to serve as 
an important guide in the search for lead molecules for the pharmaceutical 
industry. However, recovery of such molecules from plants remains a challenging 
task due to the intricacies involved in the process. The boundaries of the problem 
extend to multiple disciplines such as chemical engineering, natural product 
chemistry, and analytical chemistry. Therefore, a multidisciplinary approach 
involving coordinated efforts from all disciplines is required in order to ensure an 
economically viable isolation of important drugs from plants.  
Artemisinin, an antimalarial drug, from the plant Artemisia annua is a very good 
example of such a drug molecule. We have developed a process to isolate and 
purify artemisinin from dried leaves of A. annua by using a multidisciplinary 
approach. At first, artemisinin is extracted from the leaves with dichloromethane 
by using maceration technique followed by partial purification of crude extract 
with flash column chromatography (flash CC). Finally, pure artemisinin is 
crystallized from flash CC fractions. Chemical engineering principles combined 
with knowledge from other research disciplines have been used to identify the 
suitable separation techniques and optimize the process parameters. Extensive 
analysis of the process streams has been carried out with high performance 
liquid chromatography and mass spectrometry for identification and quantification 
of impurities. Chemometric methods have been employed to extract useful 
process information from the vast analytical data obtained [1].    
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Biofilms, defined as structured communities of bacteria embedded in a matrix of 
extracellular polymeric substances (EPS), represent the predominant lifestyle of 
bacteria. Biofilms are involved up to 80% of all human bacterial infections and 
characterized as highly resistant to antimicrobial therapy and host immune 
system [1]. Moreover, the selection of existing anti-biofilm agents is extremely 
limited, thus the demands for research in this area are enormous.  
In this work, a compound collection consisting of amino acid derivatives of 
Dehydroabietic acid (DHA), a naturally occurring resin acid from conifers, was 
synthesized, inspired by the recent identification of DHA as a potent inhibitor of 
Staphylococcus aureus biofilms as well as the reports of D-amino acids as biofilm 
dispersal agents [2, 3]. The derivatives were screened for anti-biofilm activity and 
effects on planktonic bacteria were investigated in two exposure conditions, prior-
to and post biofilm formation using resazurin staining and turbidity measurements, 
respectively. Further, mode of action studies including kinetic studies, were 
performed to assess the changes in membrane depolarization and ATP efflux 
caused by the most active compounds.  
To the best of our knowledge, the identified lead compounds here, a D-
tryptophan derivative 9b and a cyclohexyl-L-alanine derivative 11, are the most 
potent abietane-type biocides reported so far. Each of the compounds displays 
anti-biofilm activity with potency (IC50) values in the low micromolar range (33.2 
and 9.4 µM) prior-to and (86.1 and 27.9 µM) post biofilm formation, in addition to 
antibacterial activity on planktonic bacteria. 
 
Acknowledgements: Academy of Finland project 282981 and National Doctoral 
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Nigeria is rich in plants used for treatment of diabetes and its complications by 
traditional herbalists. Therefore, documentation of their knowledge as well as 
scientific validation of their claims is needed. This study aims at evaluating the 
antidiabetic potential of nine ethanolic extracts from seven plants used 
traditionally to treat diabetes. The postprandial effects were evaluated in albino 
rats divided into three groups of 5 each.  Each rat received peroral gavage, 
1mL/100g body weight of 80% w/v glucose. 30 min later, extracts were 
administered perorally in 0.5 mL 2% w/v acacia gum to two groups using doses 
of 250 and 500 mg/kg, respectively. The control group received 0.5 mL 2% w/v 
acacia gum. Blood glucose levels were monitored at 30, 60 and 120 min [1]. 
There were significant reductions (P < 0.05) in blood glucose levels after 30 mins 
in groups treated with Funtumia africana root and Diodia scandens stem 
compared to the control. Both extracts were assessed for a-glucosidase and a-
amylase inhibitory activity in vitro [2,3]. Results showed that the two extracts 
could not significantly inhibit these enzymes. Ability of the extracts to reduce the 
stable DPPH was also evaluated for all samples [4]. Dialium guineense, F. 
africana and Dalbergiella welwitchii reduced the stable DPPH by 72%, 68% and 
55% respectively. F. africana root seemed to contain little or no tannin and was 
selected for further study based on the HPLC fingerprints.The present study 
suggests that there may be other explanations for including the tested plants in 
the antidiabetic recipes. Further work is ongoing to investigate other possible 
mechanisms of action and to identify the compound(s) responsible for the radical 
scavenging activity.  
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Type 2 diabetes is a metabolic disorder estimated to affect millions of people all 
over the world [1]. One way of reducing diabetes-related complications is to 
control postprandial glucose [2]. Inhibition of the carbohydrate digestive enzyme 
α-amylase is a therapeutic target for maintaining low blood glucose levels. A 
study from 2011 shows that berries from Sorbus spp. (rowan berries) effectively 
inhibits α-amylase activity and suggests that the active compounds are 
proanthocyanidins [3]. The aim of this project is to identify the rowanberry 
species with highest α-amylase inhibitory activity - and to find a 1H-NMR method 
suitable for NMR-based metabolomics.  
Acetone extracts of 16 species of rowan berries collected in the botanical garden 
of Copenhagen were prepared - and IC50 values were assessed using a newly 
developed microplate-based α-amylase inhibition assay [4]. This showed a large 
variation in α-amylase inhibitory activity of the 16 Sorbus spp. in the in-vitro α-
amylase inhibition assay. 1H NMR spectra of all extracts were subsequently 
acquired, and the multivariate data analysis score-plot revealed a correlation 
between the α-amylase inhibitory effect and the fingerprint of the extracts. This 
information will be used in our future experiments aiming at identification of 
components responsible for the α-amylase inhibitory activity in rowanberries. 
 
 
 
 
 
 
 
 
 
Figure 1. Selection of collected  Figure 2. PCA score of comp. 2 versus IC50 
Sorbus species. values. Light pink = most active, while light  
 blue = the least active extracts 
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Chloranthaceae is a plant family consisting of four genera: Ascarina, Chloranthus, 
Hedyosmum and Sarcandra and ca. 70 species, occurring in tropical Asia. The 
whole plants or roots of plants have been used in traditional Chinese medicine to 
treat e.g. bone fractures, inflammation, cancer, and high blood pressure. 
Previous studies of this family have resulted in the isolation of various 
compounds and elucidation of some bioactivities [1]. Among these compounds 
are the sesquiterpene lactones (STLs), a group of secondary plant metabolites. 
Extracts from plants rich in STLs have gained considerable interest for treating 
human diseases since STLs hold features that make them appealing compounds 
in clinical trials [2]. 
The aim of this study was to chart the bioactivities of STLs from the family of 
Chloranthaceae in chemical property space. Over 300 STLs have been collected 
of which about 50 had reported bioactivity. Using ChemGPS-NP, a tool based on 
principal component analysis (PCA) to navigate chemical property space in 8 
dimensions, we calculated the physicochemical property of the analyzed STLs [3].  
Thought visualization in the ChemGPS-NP global map we could describe the 
large diversity found in these compounds and highlight similarities and 
differences in their physico-chemical properties. We could identify STLs that form 
cluster and occupy defined volumes in chemical property space, and correlating 
this to a particular biological activity.  
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Figure 1: ChemGPS-NP 
mapping (three first 
dimensions, PC1-PC3). Blue 
compounds represent all STLs 
found in the Chlorantaceae, 
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Cyclotides are a family of plant-derived proteins that are characterized by a cyclic 
backbone and a knotted disulfide topology [1,2]. Their cyclic cystine knot (CCK) 
motif makes them exceptionally resistant to thermal, chemical, and enzymatic 
degradation [3]. Cyclotides exert much of their biological activity via interactions 
with cell membranes. In this work, we qualitatively and quantitatively analyze the 
cytotoxic and anthelmintic membrane activities of cyclotides. The qualitative and 
quantitative models describe the potency of cyclotides using four simple 
physicochemical terms relevant to membrane contact. Specifically, surface areas 
of the cyclotides representing lipophilic and hydrogen bond donating properties 
were quantified and their distribution across the molecular surface was 
determined. The resulting quantitative structure-activity relation (QSAR) models 
[4] suggest that the activity of the cyclotides is proportional to their lipophilic and 
positively charged surface areas, provided that the distribution of these surfaces 
is asymmetric. In addition, we qualitatively analyzed the physicochemical 
differences between the various cyclotide subfamilies and their effects on the 
cyclotides’ orientation on the membrane and membrane activity.  
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Greenlandic potato farmers do not practice crop rotation or utilise fallow seasons 
due to the very limited area of arable land available. They also do not apply 
pesticides or herbicides to their crops due to the high cost of these products in 
these isolated communities. Despite the continued cultivation of a single crop, no 
fungal infections occur. Given this unusual occurrence we hypothesised that the 
lack infection was due to the presence of beneficial biocontrol organism in the 
Greenlandic potato soils. This guided approach led to the discovery of a 
Pseudomonas species which produces two classes of novel anti-fungal cyclic 
depsipeptides; the nunamycins and nunapeptins. Current work, in collaboration 
with Copenhagen University, is focused on determination the conditions which 
promote the production of these natural products and structural refinement of the 
nunapeptins. We are using MALDI-TOF and high resolution LC-MS to quickly 
analyse samples in conjunction with genetic manipulation of the biocontrol 
bacteria. We will also soon perform MALDI-TOF imaging of the bacteria in situ to 
gather further detail about the nature of the bacterial-fungal interaction. 
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Sri Lanka is a unique island, which possesses high degree of biodiversity. There 
are about 3,154 indigenous flowering plant species of flora and about quarter 
(894) of that is endemic to the country. Natural products compounds have 
recently gained popularity and scientific interest. Researchers have been 
interested in bioactive compounds from plant species for the treatment of 
infectious diseases caused by microorganisms. According to the World Health 
Organization (WHO), more than 80% of the world’s population depends on 
traditional medicine for their primary health care needs. In recent years there has 
been an emerging interest in the discovery of plant peptides with medicinal 
properties [1]. The current project aims to establish the scientific basis of plant-
derived medicinal compounds in Sri Lankan plants following anecdotal evidence 
for their use in Ayurvedic medical practice.   
In the present study, the aqueous extracts of 17 plants belonging to the family 
Rubiaceae were tested for their antimicrobial activity. Arial part of the plants were 
extracted into a mixture of CH2Cl2: MeOH=1:1 and concentrated under reduced 
pressure to obtain the crude extracts. Organic crude extracts were dissolved in 
the above solvent mixture and partitioned with MQ-water. The aqueous extracts 
(4 mg/ml) were tested against Escherichia coli (ATCC 25922), Pseudomonas 
aeruginosa (ATCC 27853), Staphylococcus aureus (ATCC 29213) and Candida 
albicans (ATCC 90028); minimum inhibitory concentration (MIC) assay was 
performed using a final concentration of microbes, 1×106 CFU/ml. The MIC value 
reported is for 100% of microbial death and the results showed that all extracts 
are active against S. aureus; all the extracts except Wendlandia bicuspidata were 
found to be inactive against gram negative bacteria and the fungal strain Candida 
albicans. Bioassay guided fractionation for the extracts with low MIC values is in 
progress. In addition, the plant extracts will be screened for cytotoxic activity 
using a fluorometric microculture cytotoxic assay (FCMA).  
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Harmful algae blooms are a reoccurring phenomenon that cause huge economic 
losses for the farmed fish industry.  This paper will describe results obtained in 
the collaborative Danish Strategic Research project: “HABFISH - Harmful algae 
and fish kills” [1]. 
We used Prymnesium parvum, a harmful algae that has caused massive blooms 
in Scandinavian waters, in our search for new bioactivities. We found huge 
ichyotoxic difference among 5 strains of P. parvum when tested on rainbow trout 
[2] Chemical analysis based on LC-DAD-HRMS showed that all tested strains 
produced GAT and oleamide – two compounds that recently have been 
suggested as the ichyotoxic component of P. parvum [3]. Although, we found no 
evidence that these compounds are ichyotoxic at ecological relevant 
concentrations. In addition, 13C feeding experiments suggested that oleamide is a 
contaminant derived from plastics, potentially extracted in sample preparation.  
Excitingly, we found that different strains of P. parvum produce at least two types 
of prymnesin-like molecules. One strain produced prymnesin 2,4 whereas 
several Scandinavian strains produce a novel type of prymnesin. Extraction of 
>100 litres of algal culture has allowed us to isolate enough material of a novel 
prymnesin-like molecule, including a 13C enriched version. This paper will report 
the status of our efforts towards structural elucidation of this large and complex 
polyketide derived polyether, based on various 2- and 3-D NMR experiments.  
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T. macroptera is a tree which grows in West Africa. In traditional medicine, The 
roots are used against hepatitis, gonorrhea and various infectious diseases. 
Various reports have shown that polysaccharides from different plants can be 
responsible for the effects associated with the healing of wounds. 
Polysaccharides of certain structures modulate the immune system and intensify 
its defence mechanism.  
Pectic polysaccharides containing rhamnogalacturonan I backbone with 
arabinogalactans type I and II structures have shown effects in a number of 
biological assays. Endo-α-ᴅ-(1-4)-polygalacturonase was performed for 
production of “hairy” or ramified regions of the polymers.  
50WTRBH-II-I, a complement fixing pectic polysaccharide, isolated from root 
bark of T. macroptera. After enzymatic treatment, the “hairy” regions were 
purified by BioGel P30 gel filtration. The main sub-fraction, 50WTRBH-II-Ia, 
showed higher activity compared to its native fraction. The methylation result 
indicated the presence of AG-I and AG-II structures in 50WTRBH-II-Ia. The 
proposed structure of 50WTRB-II-I is long homogalacturonan and short RG-I 
backbone with AG-I and AG-II branched. The results suggest that the 
complement fixation activity of this pectin is expressed mainly by its ramified 
regions. 
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The cyclotide family of plant-derived peptides is defined by a cyclic peptide 
backbone and three disulfide bonds forming a knot in its core. This cyclic and 
knotted structure renders them exceptionally stable against proteases, making 
them for example ideal grafting templates for bioactive epitopes. Many cyclotides 
have in our hands shown potent bactericidal activity. The bactericidal effect is 
derived from membrane permeabilization in a phospholipid specific manner. 
Besides the typical selectivity factors for membrane active antimicrobial peptides, 
i.e. the presence of anionic head groups and the absence of cholesterol, 
cyclotides frequently also have phosphatidylethanolamine (PE) affinity. We have 
studied the structural prerequisites for the PE-binding pocket, which alone 
increases the membrane disruption potential more than 700-fold on bacteria 
modelled liposomes. Mutations that distort the PE-binding pocket results in 
substantial loss of antimicrobial activity. Dividing bacteria, as well as tumour cells, 
present PE on the outside of their cytoplasmic membrane. The PE-affinity of 
cyclotides therefore represents a useful trait in terms of selectivity and 
broadening their potential therapeutic window as membrane active antimicrobial 
peptides. 
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The marine environment has produced a large number of biologically active and 
structurally diverse natural products [1]. In this study, 11 microalgae from the 
Oslo fjord in Norway were cultivated and investigated for their biological activity 
against cancer cells. The algae were cultivated at 18 ºC in IMR 1/2 medium. The 
cultures were filtered and the filter discs and filtrate were frozen. The frozen filter 
discs were cut in small pieces and ASE (Accelerated Solvent Extraction) 
extraction was performed yielding hexane, ethyl acetate, ethanol and water 
extracts. Diaion HP20 resin was added to the filtrate and left overnight. The 
mixture was filtered and the Diaion HP20 resin was extracted with methanol 
resulting in a lipophilic fraction. The filtrate was concentrated and applied on a 
Biogel column for desalting resulting in a hydrophilic fraction. All extracts were 
screened for viability and apoptose activity against Jurkat cells. The ethyl acetate 
extracts of several algae exhibited activity against the cell line. Prymnesium 
polylepis, Becheleria aff. cincta, Dunaliella tertiolecta and Micromonas pusilla 
were most active. Preliminary NMR studies of extracts of the most active species 
show the presence of lipophilic constituents.   
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The name truffles/terfezia comes from the word “terfass,” which is an Arabic word 
describing hypogenous desert fungus. Truffles are known as fungus growing 
underground. In general, most of desert truffles species belong to genera such as 
Terfezia, Picoa, Tirmania, and Tuber [1]. Truffle mushrooms due to their special 
flavour and organoleptic properties are increased to commercial importance and 
they are more expensive than other mushroom species. In addition, Truffles are 
consumed as a functional food to be healthy and to protect against disease. Up 
to date, Truffles have been shown several biological activities i.e. antioxidant, 
anti-inflammatory, cytotoxic [2], and antimicrobial [3].  
In this study, Terfezia olbiensis Tul. & C. Tul. (AT-1905) and Terfezia claveryi 
Chatin (AT-2063) collected from Uşak and Aksaray in Turkey extracted with 
methanol at room conditions. The methanol extracts were dissolved in water and 
re-extracted with n-hexane and ethyl acetate. The antioxidant activity of extracts 
of truffle mushrooms was performed by DPPH free radical and ABTS cation 
radical scavenging assays and the anticholinesterase activity, however, against 
acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) enzymes. 
In DPPH• assay, ethyl acetate extract of T. olbiensis showed 92.47±0.22% 
inhibition activity at 800 µg/mL concentration whereas in ABTS•+ assay, the 
methanol extract exhibited 92.47±0.22% inhibition at same concentration. The 
hexane extract of T. olbiensis demonstrated the best inhibition activity against 
AChE and BChE enzymes, indicating 63.99±1.14% and 51.44±0.29%, at 200 
µg/mL concentration, respectively. 
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Phenolic compounds, a large class of phytochemicals, are interesting biological 
properties. They are available mostly in vegetables, fruits, seeds, herbs, and 
grains, as well as in juices, oils, and wines. Several phenolic compounds 
indicating antimicrobial [1], antiviral [2] cytotoxic, antioxidant [3] activities have 
been identified from mushroom species. 
In this study, phenolic profile of Hysterangium inflatum Rodway, Reddellomyces 
westraliensis (G.W. Beaton & Malajczuk) Trappe, Castellano & Malajczuk, and 
Terfezia leptoderma Tul. & C. Tul. was identified by HPLC-DAD. The phenolic 
profile was determined according to the method of Barros et al. [4] with slight 
modification. Sixteen phenolic and organic acids i.e. gallic acid, fumaric acid, 
protocatecheuic acid, catechin hydrate, p-hydroxybenzoic acid, 6,7-dihydroxy 
coumarin, caffeic acid, vanillin, 2,4-dihydroxy benzoic acid, p-coumaric acid, 
ferulic acid, coumarin, trans-2-hydroxycinnamic acid, ellagic acid, rosmarinic acid 
and trans-cinnamic acid were analysed. Fumaric acid was found as major 
organic acid in T. leptoderma (6.57 µg/g) and R. westraliensis (27.2 µg/g) while 
catechin hydrate (1.76 µg/g) was found in H. inflatum. Gallic acid, Fumaric acid, 
Catechin hydrate, and trans-cinnamic acid were identified for all studied 
mushrooms. 
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Truffles have been used as food and medicine due to their unique taste and 
flavor as well as their chemical and nutritional properties.  
Their nutritional properties are due to high protein, fiber, vitamin and mineral 
contents and a low-fat level [1]. In this study, four ectomycorrhizal fungus 
specimens; namely, Hysterangium inflatum Rodway, Reddellomyces 
westraliensis Trappe, Castellano & Malajczuk, Reddellomyces parvulosporus 
Trappe, Castellano & Malajczuk, Setchelligaster tenuipes (Setch.) Pauzar 
collected from different localities of Muğla (Ula, Köyceğiz, Marmaris, Dalaman, 
and Fethiye) in which the spread of eucalyptus trees.  
The nutritional properties (moisture, ash, protein, fat, carbonhydrate, energy) of 
mushrooms was determined by AOAC procedures [2]. The protein content 
(N×4.38) was determined by the macro-Kjeldahl method; fat was estimated by 
extracting hexane, using a Soxhlet apparatus; ash content was calculated by 
incineration at 600±15 °C. The moisture contents of studied mushrooms were 
found to be between 66.9-81.0 g/100 g of fresh weight while the ash contents 
were between 0.05-0.48 g/100 g of dry weight. The protein and fat contents 
found in the studied mushrooms ranged 9.19-23.91 g/100 g of dry weight, and 
0.09-3.25 g/100 g of dry weight, respectively. The carbohydrate values of 
mushroom samples were calculated between 72.78-90.21 g/100 g of dry weight 
whereas energy values were between 401.11-503.67 kcal/100 g of dry weight. As 
a consequence, studied ectomycorrhizal mushrooms are rich in moisture, protein 
and energy and poor in fat. 
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The berries of Sambucus nigra have traditionally been used and are still used to 
treat respiratory illnesses such as cold and flu in Europe, Asia and America.  
Structures and immunomodulating properties of the pectic polymers from 
elderberries were elucidated. All the purified fractions obtained from the 50% 
ethanol, 50 °C water and 100 °C water extracts showed potent dose-dependent 
complement fixating activity and macrophage stimulating activity. The isolated 
fractions consisted of long homogalacturonan regions, in addition to 
arabinogalactan-I and arabinogalactan-II probably linked to a rhamnogalaturonan 
backbone. Reduced bioactivity was observed after reduction of Araf residues and 
1→3,6 Gal by weak acid hydrolysis. Rhamnogalacturonan regions were isolated 
after enzymatic degradation with endo-α-D-(1→4)-polygalacturonase and 
showed higher activity compared to the native polymer. The results from the 
linkage analysis and bioactivity tests led to the assumption that the branched 
moieties of the arabinogalactans, linked to rhamnogalacturonan region are 
important for the immunomodulating activity seen in elderberries. 
Immunomodulating polysaccharides might be responsible for the claimed effect 
of berry extracts on cold and influenza, but the ability of these polysaccharides to 
contribute to immunomodulating activity in humans remains to be fully 
investigated.  
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Syzygium guineense is a small tree with edible fruits widespread in Sub-Saharan 
Africa. Leaves are traditionally used to treat diarrhea, infections and 
stomachache. The phytochemistry of the leaves is not very well characterized; 
triterpenoids, sesquiterpenoids and polysaccharides are reported.  
In our study, the leaves of S. guineense were extracted by accelerated solvent 
extraction with dichloromethane and methanol. The methanol extract was 
fractionated by different chromatographic methods (Diaion HP-20, Sephadex LH 
20, Versaflash RP-18, and preparative HPLC C18) to yield flavonols (myricetin 
and myricetin derivatives), gallotannins and ellagitannins. NMR spectroscopy 
was employed for structure elucidation.  
The crude extracts and pure substances were investigated for radical scavenging 
properties using the diphenylpicrylhydrazyl assay, and for inhibition of the 
enzymes 15-lipoxygenase and xanthine oxidase, both of which are involved in 
peroxidative processes. The methanol extract showed high radical scavenging 
activity and was a good inhibitor of 15-lipoxygenase and xanthine oxidase. The 
activity can be explained by its high content of polyphenols. 
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Lichen is a symbiotic association between fungi and photobiotic microorganisms 
(algae and/or cyanobacteria), which presents a vast diversity of secondary 
metabolites (i.e. lichen acids) with marked pharmaceutical potentials [1]. Some 
lichen acids, such as usnic acid and protolichesterinic acid, have displayed 
antimicrobial and anti-proliferative activities [2,3]. Cetrarioid lichens comprise a 
morphological group in the Parmeliaceae (lichen-forming ascomycetes) family. 
Among the group members, is the lichen species Cetraria islandica (L.) Ach, also 
known as Iceland moss. It has been used traditionally to treat lung diseases and 
inflammation of oral and pharyngeal mucosa [4]. The aim of the study was to 
investigate if phylogeny can be used to predict phytochemical diversity of 
Icelandic cetrarioid lichens (ICLs) and to test if chemical profiles could be used as 
an aid to delimit closely related lichen taxa. A total of 73 samples representing 8 
species from 3 genera were included in phylogenetic analyses based on fungal 
nuclear ribosomal internal transcribed spacer (nrITS) and small subunit (nrSSU) 
DNA regions as well as algal nrITS sequences. Each specimen was extracted 
with acetone and the chemical profiles of crude extracts from ICLs were obtained 
with UPLC-Q-TOF-assay, and the evaluation of the data was performed with 
MarkerLynx and EZinfo. The metabolomic approach has shown great potential in 
resolving closely related species where DNA sequence failed to give sufficient 
taxonomic information.  
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The genus Aloe belongs to the sub‐ family Alooideae (Aloaceae) of the family 
Asphodelaceae. It is represented by 600 species and subspecies, which are 
native to sub‐ Saharan Africa, the Saudi Arabian Peninsula, and to many islands 
of the western Indian Ocean, including Madagascar [1]. Ethiopia is one of the 
Aloe-rich countries where 40 species, of which 20 are endemic, are so far known 
[1]. Aloes are also widely employed in the Ethiopian traditional medicine for the 
treatment of various ailments such as malaria, gastric problems, inflammation, 
wounds, infections, snakebite and diabetes. There is an ongoing work in our 
group to investigate the claimed ethnobotanical uses and phytochemistry of aloes 
in the country. More than 10 species have been screened thus far. The aloes 
were collected from their growing sites and the latex of each aloe was obtained 
by making transverse cuts on the leaves. Results of in vivo and in vitro biological 
tests showed that the aloes possess antimicrobial, antioxidant, antileshmanial 
and antimalarial activities [2-8]. On the other hand, bioassay guided fractionation 
assisted with spectroscopic techniques led to the isolation of secondary 
metabolites, mostly anthrones. The findings corroborate the claimed traditional 
uses of the plants and present potential natural products for further investigation. 
 
 
Acknowledgements: International Science Program, Uppsala University, 
Uppsala, Sweden. Postgraduate Students at our Department. 
 
 
References:  
1. Demissew S. Nordal I (2010) Aloes and Lilies of Ethiopia and Eritrea. Shama 
Books. Addis Ababa 
2. Paulos B. et al. (2011) Ethiop. Pharm. J. 29: 100-7.   
3. Asamenew G. (2011) Phytother. Res. 25: 1756-60.  
4. Gemechu W (2014) Ethiop. Pharm. J. 30: 1-9 
5. Minale G (2014) Int. J. Green Pharm 8: 7-12 
6. Abeje F (2014) Phytother. Res. 28:1801-25 
7. Teka T (2014) Int. J. Phytopharmacol. 5: 261-66 
8. Oumer A (2014) NPC 9: 949-52 
 
